Integrin-mediated	O
tyrosine	O
phosphorylation	O
and	O
cytokine	B-protein
message	O
induction	O
in	O
monocytic	B-cell_type
cells	I-cell_type
.	O

A	O
possible	O
signaling	O
role	O
for	O
the	O
Syk	B-protein
tyrosine	I-protein
kinase	I-protein
.	O

Activation	O
of	O
cytoplasmic	B-protein
tyrosine	I-protein
kinases	I-protein
is	O
an	O
important	O
aspect	O
of	O
signal	O
transduction	O
mediated	O
by	O
integrins	B-protein
.	O

In	O
the	O
human	B-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
THP-1	I-cell_line
,	O
either	O
integrin	B-protein
-dependent	O
cell	O
adhesion	O
to	O
fibronectin	B-protein
or	O
ligation	O
of	O
beta	O
1	O
integrins	O
with	O
antibodies	B-protein
causes	O
a	O
rapid	O
and	O
intense	O
tyrosine	O
phosphorylation	O
of	O
two	O
sets	O
of	O
proteins	O
of	O
about	O
65-75	B-protein
and	I-protein
120-125	I-protein
kDa	I-protein
.	O

In	O
addition	O
,	O
integrin	B-protein
ligation	O
leads	O
to	O
nuclear	O
translocation	O
of	O
the	O
p50	B-protein
and	O
p65	B-protein
subunits	I-protein
of	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factor	I-protein
,	O
to	O
activation	O
of	O
a	O
reporter	B-DNA
gene	I-DNA
driven	O
by	O
a	O
promoter	B-DNA
containing	O
NF-kappa	B-DNA
B	I-DNA
sites	I-DNA
,	O
and	O
to	O
increased	O
levels	O
of	O
mRNAs	B-RNA
for	O
immediate-early	B-DNA
genes	I-DNA
,	O
including	O
the	O
cytokine	B-protein
interleukin	I-protein
(	I-protein
IL	I-protein
)	I-protein
-1	I-protein
beta	I-protein
.	O

The	O
tyrosine	O
kinase	O
inhibitors	O
genistein	O
and	O
herbimycin	O
A	O
block	O
both	O
integrin	B-protein
-mediated	O
tyrosine	O
phosphorylation	O
and	O
increases	O
in	O
IL-1	B-protein
beta	I-protein
message	O
levels	O
,	O
indicating	O
a	O
causal	O
relationship	O
between	O
the	O
two	O
events	O
.	O

The	O
components	O
tyrosine	O
phosphorylated	O
subsequent	O
to	O
cell	O
adhesion	O
include	O
paxillin	B-protein
,	O
pp125FAK	B-protein
,	O
and	O
the	O
SH2	B-protein
domain	I-protein
containing	I-protein
tyrosine	I-protein
kinase	I-protein
Syk	I-protein
.	O

In	O
contrast	O
,	O
integrin	B-protein
ligation	O
with	O
antibodies	B-protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Syk	B-protein
but	O
not	O
of	O
FAK	B-protein
or	O
paxillin	B-protein
.	O

In	O
adhering	B-cell_type
cells	I-cell_type
,	O
pre-treatment	O
with	O
cytochalasin	O
D	O
suppresses	O
tyrosine	O
phosphorylation	O
of	O
FAK	B-protein
and	O
paxillin	B-protein
but	O
not	O
of	O
Syk	B-protein
,	O
while	O
IL-1	B-protein
beta	I-protein
message	O
induction	O
is	O
unaffected	O
.	O

These	O
observations	O
indicate	O
that	O
the	O
Syk	B-protein
tyrosine	O
kinase	O
may	O
be	O
an	O
important	O
component	O
of	O
an	O
integrin	B-protein
signaling	O
pathway	O
in	O
monocytic	B-cell_type
cells	I-cell_type
,	O
leading	O
to	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
to	O
increased	O
levels	O
of	O
cytokine	B-protein
messages	O
.	O

THE	NULL
JOURNAL	NULL
OF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

27	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
7	NULL
,	NULL
pp	NULL
.	NULL

16189-16197	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Integrin-mediated	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
in	NULL
Monocytic	NULL
Cells	NULL
A	NULL
POSSIBLE	NULL
SIGNALING	NULL
ROLE	NULL
FOR	NULL
THE	NULL
Syk	NULL
TYROSINE	NULL
KINASE*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
31	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
16	NULL
,	NULL
1995	NULL
)	NULL
Tsung	NULL
H.	NULL
Lint	NULL
,	NULL
Carlos	NULL
Rosalest	NULL
,	NULL
Krishna	NULL
Mondal§	NULL
,	NULL
Joseph	NULL
B.	NULL
Bolen1	NULL
,	NULL
Stephen	NULL
Haskill§	NULL
]	NULL
,	NULL
and	NULL
Rudy	NULL
L.	NULL
Julianot**	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
the	NULL
§Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
and	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
North	NULL
Carolina	NULL
27599	NULL
,	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
The	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Princeton	NULL
,	NULL
New	NULL
Jersey	NULL
08543	NULL
Activation	NULL
of	NULL
cytoplasmic	NULL
tyrosine	NULL
kinases	NULL
is	NULL
an	NULL
important	NULL
aspect	NULL
of	NULL
signal	NULL
transduction	NULL
mediated	NULL
by	NULL
integrins	NULL
.	NULL

In	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
,	NULL
either	NULL
integrin-dependent	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
or	NULL
ligation	NULL
of	NULL
B1	NULL
integrins	NULL
with	NULL
antibodies	NULL
causes	NULL
a	NULL
rapid	NULL
and	NULL
intense	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
two	NULL
sets	NULL
of	NULL
proteins	NULL
of	NULL
about	NULL
65-75	NULL
and	NULL
120-125	NULL
kDa	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
integrin	NULL
ligation	NULL
leads	NULL
to	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
,	NULL
to	NULL
activation	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
promoter	NULL
containing	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
and	NULL
to	NULL
increased	NULL
levels	NULL
of	NULL
mRNAs	NULL
for	NULL
immediate-early	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
cytokine	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-1	NULL
$	NULL
.	NULL

The	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
genistein	NULL
and	NULL
herbimycin	NULL
A	NULL
block	NULL
both	NULL
integrin-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
increases	NULL
in	NULL
IL-1B	NULL
message	NULL
levels	NULL
,	NULL
indicating	NULL
a	NULL
causal	NULL
relationship	NULL
between	NULL
the	NULL
two	NULL
events	NULL
.	NULL

The	NULL
components	NULL
tyrosine	NULL
phosphorylated	NULL
subsequent	NULL
to	NULL
cell	NULL
adhesion	NULL
include	NULL
paxillin	NULL
,	NULL
pp125	NULL
``	NULL
*	NULL
``	NULL
,	NULL
and	NULL
the	NULL
SH2	NULL
domain	NULL
containing	NULL
tyrosine	NULL
kinase	NULL
Syk	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
integrin	NULL
ligation	NULL
with	NULL
antibodies	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Syk	NULL
but	NULL
not	NULL
of	NULL
FAK	NULL
or	NULL
paxillin	NULL
.	NULL

In	NULL
adhering	NULL
cells	NULL
,	NULL
pre-treatment	NULL
with	NULL
cytochalasin	NULL
D	NULL
suppresses	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
FAK	NULL
and	NULL
paxillin	NULL
but	NULL
not	NULL
of	NULL
Syk	NULL
,	NULL
while	NULL
IL-16	NULL
message	NULL
induction	NULL
is	NULL
unaffected	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
the	NULL
Syk	NULL
tyrosine	NULL
kinase	NULL
may	NULL
be	NULL
an	NULL
important	NULL
component	NULL
of	NULL
an	NULL
integrin	NULL
signaling	NULL
pathway	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
and	NULL
to	NULL
increased	NULL
levels	NULL
of	NULL
cytokine	NULL
messages	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
integrin	NULL
family	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
are	NULL
involved	NULL
in	NULL
many	NULL
key	NULL
biological	NULL
processes	NULL
,	NULL
including	NULL
cell	NULL
to	NULL
cell	NULL
and	NULL
cell	NULL
to	NULL
extracellular	NULL
matrix	NULL
adhesion	NULL
,	NULL
cell	NULL
motility	NULL
,	NULL
hemo-stasis	NULL
,	NULL
lymphocyte	NULL
trafficking	NULL
,	NULL
and	NULL
inflammatory	NULL
phenomena	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Integrins	NULL
are	NULL
comprised	NULL
of	NULL
noncovalently	NULL
linked	NULL
a/f	NULL
het-erodimers	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Different	NULL
a	NULL
and	NULL
B	NULL
subunits	NULL
can	NULL
associate	NULL
in	NULL
various	NULL
combinations	NULL
,	NULL
which	NULL
then	NULL
determine	NULL
the	NULL
ligand-bind-ing	NULL
specificities	NULL
of	NULL
the	NULL
intact	NULL
integrin	NULL
heterodimer	NULL
complexes	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
become	NULL
apparent	NULL
that	NULL
integrins	NULL
function	NULL
not	NULL
only	NULL
as	NULL
adhesive	NULL
proteins	NULL
but	NULL
can	NULL
also	NULL
transduce	NULL
biochemical	NULL
signals	NULL
into	NULL
the	NULL
interior	NULL
of	NULL
the	NULL
cell	NULL
(	NULL
5	NULL
)	NULL
.	NULL

One	NULL
mode	NULL
of	NULL
integrin	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
to	NULL
S.	NULL
H.	NULL
and	NULL
R.	NULL
L	NULL
.	NULL

J	NULL
.	NULL
)	NULL

and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
(	NULL
to	NULL
R.	NULL
L	NULL
.	NULL

J	NULL
.	NULL
)	NULL

.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Pharmacology	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
CB	NULL
7365	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
919-966-4383	NULL
;	NULL
Fax	NULL
:	NULL
919-966-5640.	NULL
signal	NULL
transduction	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
cytoplasmic	NULL
tyrosine	NULL
kinases	NULL
.	NULL

In	NULL
fibroblasts	NULL
,	NULL
platelets	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
cultured	NULL
tumor	NULL
cells	NULL
,	NULL
integrin-induced	NULL
tyrosine	NULL
phosphorylation	NULL
involves	NULL
a	NULL
novel	NULL
cytoplasmic	NULL
tyrosine	NULL
kinase	NULL
termed	NULL
pp125	NULL
focal	NULL
adhesion	NULL
kinase	NULL
(	NULL
pp125	NULL
``	NULL
*4*	NULL
)	NULL
'	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
aspects	NULL
of	NULL
integrin	NULL
signaling	NULL
have	NULL
been	NULL
observed	NULL
,	NULL
including	NULL
calcium	NULL
transients	NULL
(	NULL
9	NULL
)	NULL
,	NULL
changes	NULL
in	NULL
cytoplasmic	NULL
pH	NULL
(	NULL
10	NULL
)	NULL
,	NULL
modulation	NULL
of	NULL
ion	NULL
channels	NULL
(	NULL
11	NULL
)	NULL
,	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
12	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
numerous	NULL
other	NULL
effects	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
these	NULL
later	NULL
events	NULL
and	NULL
integrin-mediated	NULL
tyrosine	NULL
phosphory	NULL
!	NULL

-ation	NULL
is	NULL
currently	NULL
unclear	NULL
.	NULL

There	NULL
have	NULL
been	NULL
observations	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
showing	NULL
that	NULL
interactions	NULL
with	NULL
the	NULL
extracellular	NULL
matrix	NULL
(	NULL
ECM	NULL
)	NULL
can	NULL
modulate	NULL
gene	NULL
expression	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

During	NULL
inflammation	NULL
,	NULL
blood	NULL
monocytes	NULL
respond	NULL
to	NULL
chemotactic	NULL
factors	NULL
and	NULL
subsequently	NULL
extravasate	NULL
into	NULL
inflamed	NULL
tissues	NULL
.	NULL

Monocytes	NULL
migrate	NULL
through	NULL
the	NULL
subendothelial	NULL
basement	NULL
membrane	NULL
and	NULL
underlying	NULL
inter-stitial	NULL
structures	NULL
rich	NULL
in	NULL
extracellular	NULL
matrix	NULL
proteins	NULL
and	NULL
also	NULL
interact	NULL
with	NULL
vascular	NULL
endothelial	NULL
cells	NULL
and	NULL
connective	NULL
tissue	NULL
cells	NULL
.	NULL

Partly	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
cell-cell	NULL
and	NULL
cell-ECM	NULL
inter-actions	NULL
,	NULL
monocytes	NULL
are	NULL
induced	NULL
to	NULL
secrete	NULL
cytokines	NULL
and	NULL
to	NULL
undergo	NULL
maturation	NULL
to	NULL
macrophages	NULL
.	NULL

Integrins	NULL
are	NULL
prominent	NULL
among	NULL
the	NULL
cell	NULL
surface	NULL
receptors	NULL
that	NULL
mediate	NULL
many	NULL
of	NULL
the	NULL
adhesive	NULL
functions	NULL
of	NULL
monocytes	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

In	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
cell	NULL
adherence	NULL
to	NULL
ECM	NULL
components	NULL
or	NULL
ligation	NULL
of	NULL
B1	NULL
integrins	NULL
with	NULL
antibodies	NULL
results	NULL
in	NULL
the	NULL
rapid	NULL
induction	NULL
of	NULL
multiple	NULL
inflammatory	NULL
mediator	NULL
genes	NULL
including	NULL
several	NULL
cytokines	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

The	NULL
5'-regulatory	NULL
regions	NULL
of	NULL
many	NULL
of	NULL
the	NULL
genes	NULL
induced	NULL
by	NULL
integrin	NULL
ligation	NULL
contain	NULL
binding	NULL
motifs	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
this	NULL
factor	NULL
in	NULL
the	NULL
gene	NULL
induction	NULL
process	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
to	NULL
gene	NULL
induction	NULL
,	NULL
a	NULL
rapid	NULL
and	NULL
profound	NULL
increase	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
observed	NULL
,	NULL
with	NULL
the	NULL
predominant	NULL
phosphorylated	NULL
compo-nent	NULL
(	NULL
s	NULL
)	NULL
having	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
about	NULL
76	NULL
kDa	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
responses	NULL
are	NULL
blocked	NULL
by	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
,	NULL
suggesting	NULL
an	NULL
important	NULL
role	NULL
for	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
integrin	NULL
signaling	NULL
pathways	NULL
,	NULL
leading	NULL
to	NULL
inflammatory	NULL
mediator	NULL
gene	NULL
induction	NULL
.	NULL

Aside	NULL
from	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
little	NULL
is	NULL
known	NULL
of	NULL
integrin-mediated	NULL
signal	NULL
transduction	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

A	NULL
significant	NULL
reason	NULL
for	NULL
this	NULL
is	NULL
the	NULL
difficulty	NULL
involved	NULL
in	NULL
performing	NULL
biochemical	NULL
or	NULL
molecular	NULL
studies	NULL
on	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
as	NULL
well	NULL
as	NULL
the	NULL
donor	NULL
to	NULL
donor	NULL
variability	NULL
observed	NULL
with	NULL
these	NULL
cells	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
are	NULL
:	NULL
FAK	NULL
,	NULL
focal	NULL
adhesion	NULL
kinase	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
ECM	NULL
,	NULL
extracellular	NULL
matrix	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

16189	NULL
16190	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
a	NULL
cell	NULL
culture	NULL
model	NULL
using	NULL
the	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
,	NULL
which	NULL
mimics	NULL
important	NULL
aspects	NULL
of	NULL
monocyte	NULL
responses	NULL
to	NULL
ECM	NULL
proteins	NULL
.	NULL

THP-1	NULL
cell	NULL
adhesion	NULL
to	NULL
ECM	NULL
proteins	NULL
or	NULL
ligation	NULL
of	NULL
B1	NULL
integrins	NULL
with	NULL
antibody	NULL
induces	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
increases	NULL
inflammatory	NULL
mediator	NULL
gene	NULL
message	NULL
levels	NULL
,	NULL
and	NULL
activates	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
.	NULL

These	NULL
responses	NULL
are	NULL
blocked	NULL
by	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
such	NULL
as	NULL
herbimycin	NULL
A	NULL
and	NULL
genistein	NULL
.	NULL

Among	NULL
the	NULL
proteins	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
THP-1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
cell	NULL
adhesion	NULL
to	NULL
ECM	NULL
components	NULL
are	NULL
the	NULL
pp125	NULL
``	NULL
*	NULL
``	NULL
(	NULL
6	NULL
,	NULL
22	NULL
)	NULL
,	NULL
the	NULL
focal	NULL
contact	NULL
protein	NULL
paxillin	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nonreceptor	NULL
tyrosine	NULL
kinase	NULL
Syk	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Ligation	NULL
of	NULL
B1	NULL
integrins	NULL
with	NULL
intact	NULL
antibodies	NULL
or	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
;	NULL
fragments	NULL
results	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Syk	NULL
but	NULL
not	NULL
of	NULL
FAK	NULL
or	NULL
paxillin	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Syk	NULL
is	NULL
accompanied	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
its	NULL
kinase	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
,	NULL
like	NULL
FAK	NULL
,	NULL
the	NULL
Syk	NULL
kinase	NULL
is	NULL
an	NULL
integrin-responsive	NULL
nonreceptor	NULL
tyrosine	NULL
kinase	NULL
.	NULL

They	NULL
also	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
Syk	NULL
is	NULL
closely	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
inflammatory	NULL
mediator	NULL
gene	NULL
messages	NULL
,	NULL
while	NULL
there	NULL
is	NULL
no	NULL
such	NULL
correlation	NULL
for	NULL
FAK	NULL
.	NULL

Thus	NULL
,	NULL
Syk	NULL
may	NULL
be	NULL
a	NULL
vital	NULL
part	NULL
of	NULL
an	NULL
integrin	NULL
signaling	NULL
pathway	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
leading	NULL
to	NULL
transcription	NULL
factor	NULL
activation	NULL
,	NULL
and	NULL
to	NULL
increased	NULL
levels	NULL
of	NULL
cytokine	NULL
messages	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-Monoclonal	NULL
antibodies	NULL
reactive	NULL
with	NULL
FAK	NULL
,	NULL
Raf-1	NULL
,	NULL
PTP1D	NULL
(	NULL
Syp	NULL
)	NULL
,	NULL
and	NULL
paxillin	NULL
,	NULL
as	NULL
well	NULL
as	NULL
goat	NULL
anti-mouse	NULL
IgG-peroxidase	NULL
and	NULL
goat	NULL
anti-rabbit	NULL
IgG-peroxidase	NULL
conjugates	NULL
,	NULL
were	NULL
purchased	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

The	NULL
anti-81	NULL
integrin	NULL
antibody	NULL
P4C10	NULL
was	NULL
obtained	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
Anti-Syk	NULL
kinase	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
raised	NULL
in	NULL
rabbits	NULL
using	NULL
fusion	NULL
proteins	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
hybridoma	NULL
TS2/16	NULL
(	NULL
anti-B1	NULL
integrin	NULL
subunit	NULL
)	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr.	NULL
M.	NULL
Hemler	NULL
(	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Research	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

TS2/16	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragment	NULL
was	NULL
prepared	NULL
by	NULL
pro-teolytic	NULL
digestion	NULL
using	NULL
a	NULL
kit	NULL
from	NULL
Pierce	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

Removal	NULL
of	NULL
intact	NULL
antibody	NULL
or	NULL
Fc	NULL
fragments	NULL
was	NULL
accomplished	NULL
using	NULL
a	NULL
protein	NULL
G	NULL
affinity	NULL
column	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
Fab	NULL
'	NULL
)	NULL
;	NULL
was	NULL
evaluated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
experiments	NULL
.	NULL

Herbimycin	NULL
A	NULL
,	NULL
genistein	NULL
,	NULL
and	NULL
calyculin	NULL
A	NULL
were	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
.	NULL

Protein	NULL
G-Sepharose	NULL
was	NULL
from	NULL
Phar-macia	NULL
Biotech	NULL
Inc.	NULL
Human	NULL
fibronectin	NULL
,	NULL
collagen	NULL
type	NULL
I	NULL
,	NULL
collagen	NULL
type	NULL
IV	NULL
,	NULL
and	NULL
laminin	NULL
,	NULL
and	NULL
the	NULL
tissue	NULL
culture	NULL
reagents	NULL
were	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
Other	NULL
reagents	NULL
and	NULL
chemicals	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

Cell	NULL
Culture-THP-1	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
heat	NULL
inactivated	NULL
)	NULL
,	NULL
50	NULL
um	NULL
2-mercaptoethanol	NULL
,	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
50	NULL
units/ml	NULL
penicillin	NULL
.	NULL

Substra-tum-coated	NULL
dishes	NULL
were	NULL
prepared	NULL
by	NULL
incubating	NULL
10	NULL
ug/ml	NULL
fibronectin	NULL
,	NULL
collagen	NULL
,	NULL
or	NULL
laminin	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
in	NULL
tissue	NULL
culture	NULL
dishes	NULL
at	NULL
4	NULL
°C	NULL
overnight	NULL
.	NULL

The	NULL
dishes	NULL
were	NULL
blocked	NULL
with	NULL
0.1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
prior	NULL
to	NULL
use	NULL
.	NULL

Adhesion	NULL
Assay-Adhesion	NULL
studies	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
a	NULL
previously	NULL
described	NULL
assay	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
48-well	NULL
tissue	NULL
culture	NULL
plates	NULL
were	NULL
coated	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
0.2	NULL
ml	NULL
of	NULL
PBS	NULL
containing	NULL
10	NULL
ug/ml	NULL
ECM	NULL
proteins	NULL
.	NULL

The	NULL
wells	NULL
were	NULL
blocked	NULL
with	NULL
0.1	NULL
%	NULL
BSA	NULL
in	NULL
PBS	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
prior	NULL
to	NULL
use	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
and	NULL
added	NULL
to	NULL
substratum-coated	NULL
wells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
cells/well	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
wells	NULL
were	NULL
washed	NULL
two	NULL
times	NULL
with	NULL
warm	NULL
PBS	NULL
and	NULL
stained	NULL
with	NULL
a	NULL
solution	NULL
containing	NULL
0.1	NULL
%	NULL
crystal	NULL
violet	NULL
and	NULL
10	NULL
%	NULL
methanol	NULL
in	NULL
PBS	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Following	NULL
three	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
the	NULL
crystal	NULL
violet	NULL
stain	NULL
was	NULL
solubilized	NULL
with	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
quantitated	NULL
by	NULL
measuring	NULL
the	NULL
absorbance	NULL
at	NULL
540	NULL
nm	NULL
.	NULL

The	NULL
absorbance	NULL
from	NULL
1	NULL
X	NULL
10°	NULL
stained	NULL
cells	NULL
was	NULL
used	NULL
to	NULL
calculated	NULL
the	NULL
number	NULL
of	NULL
adhesive	NULL
cells	NULL
per	NULL
well	NULL
.	NULL

Each	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Cell	NULL
Adherence	NULL
and	NULL
Integrin	NULL
Ligation-THP-1	NULL
cells	NULL
were	NULL
harvested	NULL
from	NULL
suspension	NULL
culture	NULL
,	NULL
washed	NULL
extensively	NULL
with	NULL
cold	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
medium	NULL
with	NULL
0.1	NULL
%	NULL
BSA	NULL
.	NULL

Cell	NULL
adherence	NULL
was	NULL
initiated	NULL
by	NULL
adding	NULL
the	NULL
cells	NULL
to	NULL
100-mm	NULL
tissue	NULL
culture	NULL
dishes	NULL
coated	NULL
with	NULL
ECM	NULL
proteins	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

For	NULL
integrin	NULL
ligation	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
or	NULL
medium	NULL
containing	NULL
intact	NULL
anti-61	NULL
IgG	NULL
,	NULL
or	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
;	NULL
fragment	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
medium	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

Preparation	NULL
of	NULL
Cell	NULL
Lysates-Cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
50	NULL
mx	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
vanadate	NULL
,	NULL
0.2	NULL
um	NULL
calyculin	NULL
A	NULL
,	NULL
5	NULL
mM	NULL
NaF	NULL
,	NULL
5	NULL
mM	NULL
sodium	NULL
pyro-phosphate	NULL
,	NULL
2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
30,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
concentration	NULL
in	NULL
the	NULL
lysates	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
bicinchonic	NULL
acid	NULL
assay	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Immunoblotting-Total	NULL
cell	NULL
lysates	NULL
from	NULL
equivalent	NULL
cell	NULL
numbers	NULL
or	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
8	NULL
%	NULL
)	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
eletrophoretically	NULL
onto	NULL
polyvinylidene	NULL
fluoride	NULL
membranes	NULL
(	NULL
Immobilon	NULL
P	NULL
,	NULL
Millipore	NULL
Corp.	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
subsequently	NULL
probed	NULL
with	NULL
primary	NULL
antibody	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
in	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

The	NULL
antibody-antigen	NULL
complexes	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
or	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
peroxidase	NULL
conjugates	NULL
,	NULL
followed	NULL
by	NULL
use	NULL
of	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
kit	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instruction	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
stripped	NULL
of	NULL
bound	NULL
antibodies	NULL
by	NULL
incubating	NULL
the	NULL
membranes	NULL
with	NULL
stripping	NULL
buffer	NULL
containing	NULL
62.5	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
6.7	NULL
,	NULL
100	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
2	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
50	NULL
°C	NULL
.	NULL

The	NULL
stripped	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
other	NULL
antibodies	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Syk	NULL
Kinase	NULL
Autophosphorylation	NULL
Assay	NULL
--	NULL
Cell	NULL
lysates	NULL
were	NULL
precleared	NULL
by	NULL
incubation	NULL
with	NULL
protein	NULL
G-Sepharose	NULL
.	NULL

The	NULL
cleared	NULL
lysates	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
anti-FAK	NULL
,	NULL
anti-Raf-1	NULL
,	NULL
anti-paxillin	NULL
,	NULL
anti-PTP1D	NULL
,	NULL
or	NULL
anti-Syk	NULL
kinase	NULL
antibody	NULL
for	NULL
3	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
additional	NULL
3	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
precipitates	NULL
were	NULL
washed	NULL
extensively	NULL
with	NULL
lysis	NULL
buffer	NULL
.	NULL

For	NULL
Western	NULL
analysis	NULL
,	NULL
the	NULL
precipitates	NULL
were	NULL
boiled	NULL
with	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
to	NULL
dissociate	NULL
the	NULL
proteins	NULL
.	NULL

For	NULL
Syk	NULL
kinase	NULL
autophosphorylation	NULL
assay	NULL
,	NULL
the	NULL
anti-Syk	NULL
immunocomplexes	NULL
were	NULL
further	NULL
washed	NULL
twice	NULL
with	NULL
kinase	NULL
assay	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
10	NULL
mm	NULL
MnCl	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
p-nitrophenyl	NULL
phosphate	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
10	NULL
LCi	NULL
of	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
)	NULL
and	NULL
2	NULL
uM	NULL
ATP	NULL
.	NULL

After	NULL
10	NULL
min	NULL
at	NULL
30	NULL
°C	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
20	NULL
ul	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
(	NULL
4x	NULL
)	NULL
and	NULL
boiling	NULL
for	NULL
3	NULL
min	NULL
.	NULL

Reporter	NULL
Gene	NULL
Assays-3XMHCwtASGCAT	NULL
,	NULL
a	NULL
construct	NULL
containing	NULL
NF-	NULL
«	NULL
B-responsive	NULL
elements	NULL
upstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyl-transferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
,	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

h-fos-lue	NULL
,	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
5'-regulatory	NULL
region	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
has	NULL
also	NULL
been	NULL
described	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
manipulated	NULL
in	NULL
various	NULL
ways	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
legends	NULL
,	NULL
and	NULL
CAT	NULL
or	NULL
luciferase	NULL
enzyme	NULL
activities	NULL
measured	NULL
using	NULL
established	NULL
protocols	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-For	NULL
EMSAs	NULL
,	NULL
THP-1	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
made	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
procedure	NULL
described	NULL
by	NULL
Cordle	NULL
and	NULL
co-workers	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Each	NULL
treatment	NULL
group	NULL
utilized	NULL
5-10	NULL
x	NULL
10°	NULL
cells	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
ice-cold	NULL
cytoplasmic	NULL
extraction	NULL
buffer	NULL
(	NULL
CEB	NULL
)	NULL
(	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
60	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
)	NULL
.	NULL

After	NULL
equilibration	NULL
in	NULL
CEB	NULL
for	NULL
5	NULL
min	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
lysed	NULL
on	NULL
ice	NULL
in	NULL
50	NULL
%	NULL
the	NULL
packed	NULL
cell	NULL
volume	NULL
of	NULL
Nonidet	NULL
P-40/CEB/PI	NULL
(	NULL
CEB	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
50	NULL
ug/ml	NULL
antipain	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
40	NULL
ug/ml	NULL
bestatin	NULL
,	NULL
3	NULL
ug/ml	NULL
E64	NULL
,	NULL
1	NULL
mM	NULL
1,10-phenanthroline	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
chymostatin	NULL
)	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
equilibrated	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
ice-cold	NULL
CEB	NULL
buffer	NULL
and	NULL
subsequently	NULL
recovered	NULL
from	NULL
the	NULL
tissue	NULL
culture	NULL
dish	NULL
by	NULL
gently	NULL
scraping	NULL
the	NULL
cells	NULL
into	NULL
500	NULL
ul	NULL
of	NULL
Nonidet	NULL
P-40/CEB/PI	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
washed	NULL
in	NULL
cold	NULL
CEB	NULL
containing	NULL
protease	NULL
inhibitors	NULL
but	NULL
no	NULL
detergent	NULL
and	NULL
then	NULL
suspended	NULL
and	NULL
mixed	NULL
in	NULL
25	NULL
pl	NULL
of	NULL
nuclear	NULL
extraction	NULL
buffer	NULL
(	NULL
NEB	NULL
)	NULL
(	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1.5	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
50	NULL
ug/m	NULL
!	NULL

antipain	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
40	NULL
ug/ml	NULL
bestatin	NULL
,	NULL
3	NULL
ug/ml	NULL
E64	NULL
,	NULL
1	NULL
mM	NULL
1,10-phenanthroline	NULL
,	NULL
100	NULL
ug/ml	NULL
chymostatin	NULL
,	NULL
and	NULL
25	NULL
%	NULL
glyc-erol	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
of	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
(	NULL
nuclear	NULL
extracts	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
snap-frozen	NULL
on	NULL
dry	NULL
ice	NULL
before	NULL
storing	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
bicinchoninic	NULL
acid	NULL
method	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
by	NULL
a	NULL
slight	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
we	NULL
previously	NULL
reported	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
DNA-protein	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
10	NULL
mii	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
5	NULL
mg	NULL
of	NULL
BSA	NULL
,	NULL
0.3	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
4	NULL
%	NULL
Ficoll	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
.	NULL

Each	NULL
reaction	NULL
contained	NULL
1	NULL
ug	NULL
of	NULL
THP-1	NULL
nuclear	NULL
extract	NULL
and	NULL
10-20,000	NULL
cpm	NULL
of	NULL
3	NULL
x	NULL
MHC	NULL
enhancer	NULL
probe	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
EMSAs	NULL
,	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
were	NULL
identified	NULL
in	NULL
shifted	NULL
complexes	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
using	NULL
supershifting	NULL
or	NULL
blocking	NULL
antibodies	NULL
against	NULL
the	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
Rel	NULL
components	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

RNA	NULL
Isolation	NULL
and	NULL
Northern	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidium	NULL
isothiocyanate-phenol-chloroform	NULL
extraction	NULL
method	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Northern	NULL
analysis	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
a	NULL
published	NULL
procedure	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
on	NULL
1.2	NULL
%	NULL
agarose-formaldehyde	NULL
gels	NULL
,	NULL
transferred	NULL
onto	NULL
polyvinylidene	NULL
fluoride	NULL
membranes	NULL
(	NULL
Immobilon	NULL
N	NULL
,	NULL
Millipore	NULL
)	NULL
,	NULL
and	NULL
fixed	NULL
to	NULL
the	NULL
membrane	NULL
by	NULL
UV	NULL
irradiation	NULL
.	NULL

Human	NULL
cDNA	NULL
probes	NULL
for	NULL
IL-1	NULL
(	NULL
20	NULL
)	NULL
and	NULL
B-actin	NULL
(	NULL
Clontech	NULL
)	NULL
were	NULL
labeled	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
kit	NULL
(	NULL
U.S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
with	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
denatured	NULL
probe	NULL
at	NULL
60	NULL
°C	NULL
overnight	NULL
in	NULL
hybridization	NULL
buffer	NULL
(	NULL
0.5	NULL
M	NULL
sodium	NULL
phosphate	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
1	NULL
%	NULL
BSA	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
7	NULL
%	NULL
SDS	NULL
)	NULL
and	NULL
were	NULL
0.8	NULL
7	NULL
o	NULL
@	NULL
i	NULL
0	NULL
fo	NULL
Adherent	NULL
cells	NULL
x	NULL
103/mm*	NULL
o	NULL
>	NULL
1	NULL
S	NULL
RGD	NULL
_	NULL
RGE	NULL
Anti-fi	NULL
_	NULL
IgG	NULL
Cells	NULL
treated	NULL
with	NULL
Dish	NULL
coated	NULL
with	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

THP-1	NULL
cells	NULL
adhere	NULL
to	NULL
ECM	NULL
components	NULL
via	NULL
integrins	NULL
.	NULL

A	NULL
,	NULL
THP-1	NULL
cells	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
were	NULL
plated	NULL
on	NULL
to	NULL
tissue	NULL
culture	NULL
plates	NULL
(	NULL
48-well	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
cells/well	NULL
)	NULL
coated	NULL
with	NULL
fibronectin	NULL
(	NULL
Fn	NULL
)	NULL
,	NULL
laminin	NULL
(	NULL
Ln	NULL
)	NULL
,	NULL
collagen	NULL
type	NULL
I	NULL
(	NULL
Cn	NULL
I	NULL
)	NULL
,	NULL
or	NULL
collagen	NULL
type	NULL
IV	NULL
(	NULL
Cnr	NULL
IV	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
cell	NULL
adhesion	NULL
assay	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Greater	NULL
than	NULL
95	NULL
%	NULL
of	NULL
cells	NULL
adhered	NULL
to	NULL
fibronectin-coated	NULL
wells	NULL
,	NULL
while	NULL
less	NULL
than	NULL
3	NULL
%	NULL
of	NULL
cells	NULL
adhered	NULL
to	NULL
control	NULL
wells	NULL
(	NULL
BSA	NULL
blocked	NULL
)	NULL
.	NULL

The	NULL
values	NULL
shown	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
determinations	NULL
.	NULL

B	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
RPMI	NULL
1640	NULL
medium	NULL
or	NULL
medium	NULL
containing	NULL
RGDS	NULL
peptide	NULL
(	NULL
10	NULL
mx	NULL
)	NULL
,	NULL
RGES	NULL
peptide	NULL
(	NULL
10	NULL
mM	NULL
)	NULL
,	NULL
anti-B1	NULL
integrin	NULL
antibody	NULL
(	NULL
ascites	NULL
of	NULL
clone	NULL
P4C10	NULL
,	NULL
1:10	NULL
dilution	NULL
)	NULL
,	NULL
or	NULL
normal	NULL
mouse	NULL
IgG	NULL
(	NULL
0.5	NULL
mg/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
plated	NULL
on	NULL
to	NULL
fibronectin-coated	NULL
48-well	NULL
plates	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
the	NULL
cell	NULL
adhesion	NULL
assay	NULL
.	NULL

The	NULL
values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
assays	NULL
.	NULL

A	NULL
0	NULL
75	NULL
15	NULL
30	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
IL-1B	NULL
message	NULL
expression	NULL
by	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin-coated	NULL
dishes	NULL
or	NULL
B1	NULL
integrin	NULL
ligation	NULL
.	NULL

A	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
fibronectin-coated	NULL
dishes	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

B	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
nonadherently	NULL
(	NULL
NAD	NULL
)	NULL
,	NULL
plated	NULL
on	NULL
fibronectin-coated	NULL
dishes	NULL
(	NULL
Fr	NULL
)	NULL
,	NULL
or	NULL
treated	NULL
with	NULL
the	NULL
anti-B1	NULL
integrin	NULL
antibody	NULL
TS2/16	NULL
at	NULL
4	NULL
°C	NULL
&	NULL
and	NULL
then	NULL
incubated	NULL
nonadherently	NULL
at	NULL
37	NULL
°C	NULL
(	NULL
B1	NULL
)	NULL
.	NULL

C	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
or	NULL
medium	NULL
containing	NULL
anti-B1	NULL
antibody	NULL
TS2/16	NULL
or	NULL
its	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragment	NULL
(	NULL
both	NULL
2	NULL
ug/ml	NULL
)	NULL
for	NULL
45	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
RPMI	NULL
1640	NULL
medium	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

For	NULL
Western	NULL
blotting	NULL
(	NULL
top	NULL
panels	NULL
)	NULL
,	NULL
cell	NULL
lysates	NULL
harvested	NULL
after	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
or	NULL
at	NULL
the	NULL
times	NULL
as	NULL
indicated	NULL
in	NULL
A	NULL
were	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
anti-	NULL
0	NULL
body	NULL
(	NULL
100	NULL
ug	NULL
of	NULL
protein/lane	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blotting	NULL
(	NULL
middle	NULL
and	NULL
bottom	NULL
panels	NULL
)	NULL
,	NULL
total	NULL
cellular	NULL
RNA	NULL
isolated	NULL
after	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
or	NULL
at	NULL
the	NULL
times	NULL
as	NULL
indicated	NULL
in	NULL
A	NULL
was	NULL
probed	NULL
with	NULL
IL-1	NULL
or	NULL
B-actin	NULL
cDNA	NULL
probes	NULL
(	NULL
6	NULL
ug	NULL
total	NULL
RNA/lane	NULL
)	NULL
.	NULL

215-	NULL
105-	NULL
43-	NULL
15	NULL
#	NULL
®	NULL
#	NULL
#	NULL
D	NULL
WD	NULL
-s-actin	NULL
16191	NULL
washed	NULL
at	NULL
60	NULL
°C	NULL
three	NULL
times	NULL
with	NULL
washing	NULL
buffer	NULL
(	NULL
40	NULL
mM	NULL
sodium	NULL
phosphate	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
%	NULL
SDS	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
visualized	NULL
by	NULL
exposing	NULL
the	NULL
membranes	NULL
to	NULL
films	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

RESULTS	NULL
THP-1	NULL
Cells	NULL
Adhere	NULL
to	NULL
ECM	NULL
Components	NULL
via	NULL
Integrins-We	NULL
surveyed	NULL
the	NULL
expression	NULL
of	NULL
integrins	NULL
on	NULL
the	NULL
THP-1	NULL
cell	NULL
surface	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

THP-1	NULL
cells	NULL
maintained	NULL
in	NULL
suspension	NULL
culture	NULL
expressed	NULL
several	NULL
integrin	NULL
subunits	NULL
including	NULL
B1	NULL
,	NULL
B2	NULL
,	NULL
«	NULL
2	NULL
,	NULL
«	NULL
3	NULL
,	NULL
«	NULL
4	NULL
,	NULL
and	NULL
«	NULL
5	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
whether	NULL
these	NULL
cells	NULL
could	NULL
adhere	NULL
to	NULL
ECM	NULL
component-coated	NULL
substrata	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14A	NULL
,	NULL
THP-1	NULL
cells	NULL
adhered	NULL
to	NULL
tissue	NULL
culture	NULL
plates	NULL
coated	NULL
with	NULL
fibronectin	NULL
,	NULL
laminin	NULL
,	NULL
collagen	NULL
type	NULL
I	NULL
,	NULL
or	NULL
collagen	NULL
type	NULL
IV	NULL
.	NULL

THP-1	NULL
cells	NULL
exhibited	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
cell	NULL
adhesion	NULL
to	NULL
the	NULL
fibronectin	NULL
substratum	NULL
,	NULL
a	NULL
moderate	NULL
level	NULL
of	NULL
adherence	NULL
to	NULL
laminin	NULL
,	NULL
and	NULL
lower	NULL
levels	NULL
of	NULL
cell	NULL
adhesion	NULL
to	NULL
collagen	NULL
type	NULL
I	NULL
or	NULL
collagen	NULL
type	NULL
IV	NULL
,	NULL
while	NULL
only	NULL
a	NULL
few	NULL
cells	NULL
adhered	NULL
to	NULL
albumin-coated	NULL
control	NULL
wells	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
was	NULL
specifically	NULL
mediated	NULL
by	NULL
integrins	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
RGDS	NULL
peptide	NULL
or	NULL
with	NULL
a	NULL
mouse	NULL
antibody	NULL
recognizing	NULL
the	NULL
B1	NULL
integrin	NULL
subunit	NULL
.	NULL

Fig	NULL
.	NULL

1B	NULL
shows	NULL
that	NULL
both	NULL
RGDS	NULL
peptide	NULL
and	NULL
anti-B1	NULL
integrin	NULL
antibody	NULL
inhibited	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
,	NULL
whereas	NULL
treatment	NULL
with	NULL
RGES	NULL
peptide	NULL
or	NULL
normal	NULL
mouse	NULL
IgG	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
THP-1	NULL
cells	NULL
use	NULL
B1	NULL
integrins	NULL
to	NULL
interact	NULL
with	NULL
and	NULL
adhere	NULL
to	NULL
ECM	NULL
components	NULL
such	NULL
as	NULL
fibronectin	NULL
.	NULL

Engagement	NULL
of	NULL
THP-1	NULL
Cell	NULL
Integrins	NULL
Increases	NULL
Protein	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
IL-1B	NULL
Message	NULL
Levels-THP-1	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
fibronectin-coated	NULL
dishes	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
(	NULL
7.5-60	NULL
min	NULL
)	NULL
.	NULL

Lysates	NULL
from	NULL
adherent	NULL
cells	NULL
were	NULL
examined	NULL
for	NULL
protein	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
residues	NULL
by	NULL
using	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
gave	NULL
rise	NULL
to	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
proteins	NULL
,	NULL
including	NULL
three	NULL
broad	NULL
bands	NULL
centered	NULL
around	NULL
67	NULL
,	NULL
71	NULL
,	NULL
and	NULL
120	NULL
kDa	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
readily	NULL
detected	NULL
7.5	NULL
min	NULL
after	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
to	NULL
the	NULL
fibronectin	NULL
substratum	NULL
,	NULL
reached	NULL
a	NULL
maximal	NULL
level	NULL
after	NULL
15	NULL
min	NULL
,	NULL
and	NULL
then	NULL
declined	NULL
,	NULL
but	NULL
was	NULL
still	NULL
significantly	NULL
elevated	NULL
after	NULL
1	NULL
h.	NULL
Cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
also	NULL
induced	NULL
increased	NULL
message	NULL
levels	NULL
of	NULL
the	NULL
inflam-	NULL
B	NULL
C	NULL
TS2/16	NULL
60	NULL
Min	NULL
NAD	NULL
Fn	NULL
Bi	NULL
NAD	NULL
IgG	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
215-	NULL
215-	NULL
a	NULL
-	NULL
_	NULL
``	NULL
Ts	NULL
-	NULL
°	NULL
_	NULL
s	NULL
``	NULL
\	NULL
We	NULL
~	NULL
4	NULL
een	NULL
woe	NULL
|	NULL
de	NULL
>	NULL
43-	NULL
43-	NULL
#	NULL
\	NULL
/	NULL
«	NULL
»	NULL
UD	NULL
#	NULL
D	NULL
30	NULL
60	NULL
120	NULL
Min	NULL
Wwe	NULL
we	NULL
-IL-18	NULL
«	NULL
o	NULL
wan	NULL
wa	NULL
#	NULL
B	NULL
we	NULL
-i-1s	NULL
.	NULL

.	NULL

Wp	NULL
-s-actin	NULL
..	NULL
.	NULL

-B-actin	NULL
16192	NULL
A	NULL
800	NULL
300000	NULL
2	NULL
~	NULL
600	NULL
7	NULL
€	NULL
&	NULL
g	NULL
>	NULL
200000	NULL
5	NULL
3	NULL
>	NULL
4004	NULL
4	NULL
6	NULL
<	NULL
0	NULL
fa	NULL
i	NULL
°	NULL
bert	NULL
5	NULL
100000	NULL
9	NULL
£	NULL
200	NULL
7	NULL
g	NULL
P	NULL
0	NULL
-	NULL
0	NULL
NF-kB	NULL
_	NULL
Mut	NULL
NF-kB	NULL
B	NULL
1200	NULL
E	NULL
-	NULL
1000	NULL
a.	NULL
L	NULL
800	NULL
2	NULL
a	NULL
600	NULL
be	NULL
o	NULL
<	NULL
400	NULL
<	NULL
o	NULL
200	NULL
0	NULL
Suspension	NULL
Fn	NULL
IgG	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
2	NULL
TS2/16	NULL
C	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
D	NULL
b	NULL
d	NULL
od	NULL
dod	NULL
d	NULL
d	NULL
Gd	NULL
d	NULL
d	NULL
d	NULL
wiem	NULL
:	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
integrin	NULL
ligation	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
NF-kB-driven	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
a	NULL
c-fos-driven	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
(	NULL
3	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
%	NULL
BSA	NULL
in	NULL
RPMI	NULL
medium	NULL
and	NULL
left	NULL
in	NULL
suspension	NULL
or	NULL
plated	NULL
on	NULL
fibronectin-coated	NULL
60-mm	NULL
dishes	NULL
.	NULL

NF-	NULL
«	NULL
B-transfected	NULL
cells	NULL
were	NULL
also	NULL
stimulated	NULL
with	NULL
5	NULL
ug/ml	NULL
anti-Bl	NULL
integrin	NULL
TS2/16	NULL
mAb	NULL
IgG	NULL
or	NULL
TS2/16	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
followed	NULL
by	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
goat	NULL
anti-mouse	NULL
Ab	NULL
for	NULL
60	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
24	NULL
h	NULL
later	NULL
and	NULL
lysed	NULL
to	NULL
measure	NULL
CAT	NULL
activity	NULL
or	NULL
6	NULL
h	NULL
later	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

c-fos-transfected	NULL
cells	NULL
were	NULL
also	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
6	NULL
h	NULL
later	NULL
.	NULL

In	NULL
A	NULL
,	NULL
solid	NULL
bars	NULL
represent	NULL
non-adherent	NULL
cells	NULL
,	NULL
hatched	NULL
bars	NULL
represent	NULL
cells	NULL
adhered	NULL
to	NULL
Fn	NULL
,	NULL
stippled	NULL
bars	NULL
represent	NULL
cells	NULL
treated	NULL
with	NULL
phorbol	NULL
ester	NULL
.	NULL

Data	NULL
are	NULL
+8.E	NULL
.	NULL

Panel	NULL
C	NULL
depicts	NULL
the	NULL
results	NULL
of	NULL
gel	NULL
shift	NULL
assays	NULL
using	NULL
a	NULL
probe	NULL
containing	NULL
NF-kB	NULL
motifs	NULL
from	NULL
the	NULL
class	NULL
I	NULL
MHC	NULL
enhancer	NULL
;	NULL
the	NULL
experimental	NULL
conditions	NULL
are	NULL
the	NULL
same	NULL
as	NULL
Panels	NULL
A	NULL
and	NULL
B	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
the	NULL
NF-kB	NULL
p50/p65	NULL
heterodimer	NULL
was	NULL
confirmed	NULL
by	NULL
supershifting	NULL
the	NULL
p65	NULL
band	NULL
and	NULL
blocking	NULL
the	NULL
p50	NULL
band	NULL
with	NULL
specific	NULL
antibodies	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
faster	NULL
moving	NULL
band	NULL
was	NULL
similarly	NULL
identified	NULL
as	NULL
p50/p50	NULL
homodimer	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
after	NULL
1	NULL
h	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
after	NULL
overnight	NULL
stimulation	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
under	NULL
the	NULL
following	NULL
conditions	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
6	NULL
,	NULL
adherence	NULL
to	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
matory	NULL
mediator	NULL
gene	NULL
IL-1	NULL
$	NULL
B	NULL
.	NULL

Fig	NULL
.	NULL

24	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
shows	NULL
that	NULL
maximal	NULL
induction	NULL
of	NULL
IL-1B	NULL
message	NULL
was	NULL
reached	NULL
1	NULL
h	NULL
after	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
began	NULL
.	NULL

By	NULL
comparing	NULL
the	NULL
time	NULL
courses	NULL
,	NULL
it	NULL
can	NULL
be	NULL
seen	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
occurred	NULL
prior	NULL
to	NULL
IL-1B	NULL
message	NULL
expression	NULL
.	NULL

The	NULL
adhesion-induced	NULL
increase	NULL
in	NULL
IL-1B	NULL
message	NULL
over	NULL
basal	NULL
levels	NULL
was	NULL
approximately	NULL
4-5-fold	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
certain	NULL
other	NULL
cytokine	NULL
messages	NULL
(	NULL
e.g	NULL
.	NULL

IL-8	NULL
)	NULL
are	NULL
also	NULL
increased	NULL
upon	NULL
THP-1	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antibody-mediated	NULL
ligation	NULL
of	NULL
integrins	NULL
has	NULL
been	NULL
previously	NULL
used	NULL
to	NULL
mimic	NULL
the	NULL
integrin	NULL
clustering	NULL
process	NULL
that	NULL
occurs	NULL
during	NULL
formation	NULL
of	NULL
adhesive	NULL
contacts	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Nonadherent	NULL
THP-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
anti-B1	NULL
integrin	NULL
antibody	NULL
TS2/16	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
message	NULL
levels	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
ligation	NULL
of	NULL
B1	NULL
integrins	NULL
resulted	NULL
in	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
although	NULL
the	NULL
pattern	NULL
was	NULL
somewhat	NULL
different	NULL
from	NULL
that	NULL
induced	NULL
by	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

With	NULL
antibody	NULL
ligation	NULL
,	NULL
bands	NULL
at	NULL
about	NULL
115	NULL
and	NULL
67	NULL
kDa	NULL
were	NULL
most	NULL
prominent	NULL
.	NULL

Ligation	NULL
of	NULL
B1	NULL
integrins	NULL
with	NULL
antibody	NULL
could	NULL
also	NULL
increase	NULL
IL-1B	NULL
message	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
middle	NULL
panel	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
message	NULL
expression	NULL
by	NULL
anti-Bl	NULL
antibody	NULL
was	NULL
not	NULL
due	NULL
to	NULL
engagement	NULL
of	NULL
Fc	NULL
receptors	NULL
,	NULL
since	NULL
TS2/16	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
IL-1B	NULL
message	NULL
as	NULL
effectively	NULL
as	NULL
intact	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Integrin	NULL
Ligation	NULL
Leads	NULL
to	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B-To	NULL
determine	NULL
whether	NULL
integrin	NULL
ligation	NULL
might	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
initiation	NULL
of	NULL
transcription	NULL
,	NULL
we	NULL
employed	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
as	NULL
well	NULL
as	NULL
reporter	NULL
gene	NULL
assays	NULL
.	NULL

Since	NULL
the	NULL
IL-1	NULL
promoter	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
promoters	NULL
for	NULL
several	NULL
other	NULL
monocyte	NULL
immediate-early	NULL
genes	NULL
,	NULL
contains	NULL
NF-kB	NULL
motifs	NULL
(	NULL
5	NULL
)	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
focus	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
complex	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
several	NULL
copies	NULL
of	NULL
the	NULL
NF-kB	NULL
motif	NULL
driving	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
,	NULL
by	NULL
a	NULL
similar	NULL
plasmid	NULL
with	NULL
mutated	NULL
NF-kB	NULL
sites	NULL
,	NULL
or	NULL
by	NULL
a	NULL
luciferase	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
THP	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
resulted	NULL
in	NULL
a	NULL
substantial	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
construct	NULL
containing	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
mutated	NULL
NF-kB	NULL
construct	NULL
.	NULL

Expression	NULL
of	NULL
luciferase	NULL
driven	NULL
by	NULL
the	NULL
c-fos	NULL
promoter	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
cell	NULL
adhesion	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
results	NULL
observed	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-driven	NULL
vector	NULL
were	NULL
not	NULL
due	NULL
to	NULL
generalized	NULL
increases	NULL
in	NULL
transcriptional	NULL
activity	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-driven	NULL
reporter	NULL
could	NULL
be	NULL
triggered	NULL
by	NULL
integrin	NULL
ligation	NULL
with	NULL
intact	NULL
anti-B1	NULL
antibody	NULL
or	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
of	NULL
the	NULL
antibody	NULL
,	NULL
suggesting	NULL
that	NULL
integrin	NULL
ligation	NULL
,	NULL
rather	NULL
than	NULL
cell	NULL
adhesion	NULL
,	NULL
was	NULL
sufficient	NULL
for	NULL
reporter	NULL
activation	NULL
.	NULL

Integrin	NULL
ligation	NULL
by	NULL
antibodies	NULL
or	NULL
integrin-mediated	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
also	NULL
caused	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
the	NULL
NF-kB	NULL
complex	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
using	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
MHC	NULL
class	NULL
I	NULL
enhancer	NULL
NF-KB	NULL
site	NULL
,	NULL
within	NULL
1	NULL
h	NULL
there	NULL
was	NULL
a	NULL
strong	NULL
increase	NULL
in	NULL
bands	NULL
representing	NULL
p50	NULL
and	NULL
p65	NULL
complexes	NULL
;	NULL
an	NULL
even	NULL
more	NULL
robust	NULL
effect	NULL
was	NULL
observed	NULL
after	NULL
overnight	NULL
stimulation	NULL
.	NULL

Use	NULL
of	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
IL-16	NULL
NF-kB	NULL
motif	NULL
gave	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
,	NULL
along	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
assays	NULL
,	NULL
suggest	NULL
that	NULL
integrin	NULL
ligation	NULL
can	NULL
activate	NULL
NF-kB	NULL
,	NULL
allowing	NULL
this	NULL
factor	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
stimulation	NULL
of	NULL
tran	NULL
fibronectin	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
,	NULL
no	NULL
stimulation	NULL
(	NULL
controls	NULL
)	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
,	NULL
TS2/16	NULL
antibody	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
,	NULL
TS2/16	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
,	NULL
TS2/16	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
goat	NULL
anti-mouse	NULL
second	NULL
antibody	NULL
.	NULL

Individual	NULL
components	NULL
were	NULL
identified	NULL
by	NULL
interference	NULL
with	NULL
the	NULL
mobility	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
;	NULL
lane	NULL
11	NULL
is	NULL
the	NULL
same	NULL
as	NULL
lane	NULL
10	NULL
but	NULL
is	NULL
pretreated	NULL
with	NULL
anti-p65	NULL
;	NULL
lane	NULL
12	NULL
,	NULL
pretreated	NULL
with	NULL
anti-p50	NULL
;	NULL
lane	NULL
13	NULL
,	NULL
pretreated	NULL
with	NULL
anti-c-rel	NULL
.	NULL

Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
A	NULL
Adhesion	NULL
to	NULL
Fn	NULL
16193	NULL
B	NULL
C	NULL
Adhesion	NULL
to	NULL
Fn	NULL
B1	NULL
crosslinking	NULL
NAD	NULL
Herbimycin	NULL
A	NULL
,	NULL
pM	NULL
_	NULL
NAD	NULL
_	NULL
Genistein	NULL
,	NULL
rm	NULL
NAD	NULL
__ber	NULL
.	NULL

__	NULL
__	NULL
_Gen	NULL
.	NULL

_	NULL
0	NULL
2	NULL
10	NULL
0	NULL
20	NULL
00	NULL
0	NULL
-	NULL
2	NULL
10	NULL
20	NULL
100	NULL
pM	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Inhibition	NULL
of	NULL
adhesion-	NULL
and	NULL
integrin	NULL
ligation-induced	NULL
tyrosine	NULL
_	NULL
215-phosphorylation	NULL
and	NULL
IL-1	NULL
8	NULL
mRNA	NULL
expression	NULL
by	NULL
herbimycin	NULL
A	NULL
or	NULL
genistein	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
pretreated	NULL
at	NULL
wire	NULL
.	NULL

swith	NULL
105-	NULL
we	NULL
«	NULL
«	NULL
®	NULL
37	NULL
°C	NULL
with	NULL
the	NULL
concentrations	NULL
(	NULL
indicated	NULL
_	NULL
!	NULL

~	NULL
o	NULL
in	NULL
the	NULL
figure	NULL
)	NULL
of	NULL
herbimycin	NULL
A	NULL
for	NULL
4	NULL
h	NULL
or	NULL
of	NULL
genistein	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
then	NULL
in-	NULL
a	NULL
10-cubated	NULL
nonadherently	NULL
(	NULL
NAD	NULL
)	NULL
or	NULL
plated	NULL
170-	NULL
y	NULL
on	NULL
fibronectin-coated	NULL
dishes	NULL
(	NULL
ADH	NULL
)	NULL
(	NULL
pan-	NULL
.	NULL

%	NULL
‘	NULL
«	NULL
aap	NULL
am	NULL
saat	NULL
els	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
or	NULL
they	NULL
were	NULL
ligated	NULL
with	NULL
k	NULL
anti-B1	NULL
integrin	NULL
antibody	NULL
at	NULL
4°C	NULL
(	NULL
B1	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
incubated	NULL
nonadherently	NULL
at	NULL
43-37	NULL
°C	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

For	NULL
Western	NULL
blotting	NULL
(	NULL
top	NULL
a	NULL
panels	NULL
)	NULL
,	NULL
cell	NULL
lysates	NULL
harvested	NULL
after	NULL
30	NULL
3-min	NULL
of	NULL
incubation	NULL
were	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
(	NULL
100	NULL
ug	NULL
of	NULL
protein/lane	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blotting	NULL
(	NULL
middle	NULL
and	NULL
bottom	NULL
panels	NULL
)	NULL
,	NULL
total	NULL
cellular	NULL
RNA	NULL
\	NULL
/\	NULL
/	NULL
N	NULL
/	NULL
isolated	NULL
after	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
was	NULL
probed	NULL
with	NULL
or	NULL
B-actin	NULL
probe	NULL
(	NULL
6	NULL
ug	NULL
<	NULL
mb	NULL
wae	NULL
-IL-1B	NULL
Pea	NULL
act	NULL
-IL-1B	NULL
total	NULL
.	NULL

band	NULL
0080	NULL
-	NULL
oe	NULL
e	NULL
as-	NULL
P	NULL
O	NULL
A	NULL
B	NULL
IP	NULL
:	NULL
anti-Syk	NULL
IP	NULL
:	NULL
anti-Rat-1	NULL
IP	NULL
:	NULL
anti-PTP1D	NULL
___	NULL
iP	NULL
:	NULL
anti-Paxillin	NULL
IP	NULL
:	NULL
anti-FAK	NULL
TS2/16	NULL
NAD	NULL
Fn	NULL
B1	NULL
NAD	NULL
Fn	NULL
Bi	NULL
_	NULL
NAD	NULL
Fn	NULL
Bi	NULL
_	NULL
NAD	NULL
Fn	NULL
B1	NULL
NAD	NULL
1gG	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
»	NULL
sven	NULL
105-70-	NULL
«	NULL
ane	NULL
«	NULL
ath	NULL
lle	NULL
.	NULL

@	NULL
»	NULL
Jee	NULL
Blot	NULL
:	NULL
anti-PY	NULL
Blot	NULL
:	NULL
anti-PY	NULL
Blot	NULL
:	NULL
anti-PY	NULL
Blot	NULL
:	NULL
anti-PY	NULL
Blot	NULL
:	NULL
anti-PY	NULL
Blot	NULL
:	NULL
anti-PY	NULL
«	NULL
o	NULL
an	NULL
a	NULL
»	NULL
@	NULL
»	NULL
#	NULL
D	NULL
a	NULL
»	NULL
#	NULL
s	NULL
ug	NULL
W	NULL
t	NULL
ae	NULL
--	NULL
-	NULL
_	NULL
on	NULL
#	NULL
p	NULL
won	NULL
Blot	NULL
:	NULL
anti-Syk	NULL
__	NULL
Blotanti-Raf-1	NULL
_	NULL
Blot	NULL
:	NULL
anti-PTP1D	NULL
Blot	NULL
:	NULL
anti-Paxillin	NULL
_	NULL
Blot	NULL
anti-FAK	NULL
Blot	NULL
:	NULL
anti-Syk	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
FAK	NULL
,	NULL
paxillin	NULL
,	NULL
and/or	NULL
Syk	NULL
kinase	NULL
by	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
or	NULL
by	NULL
B1	NULL
integrin	NULL
ligation	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
fibronectin-coated	NULL
dishes	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
or	NULL
ligated	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
the	NULL
anti-B1	NULL
integrin	NULL
antibody	NULL
TS2/16	NULL
or	NULL
its	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragment	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
in	NULL
suspension	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Following	NULL
the	NULL
incubations	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antibodies	NULL
to	NULL
PTP1D	NULL
,	NULL
Raf-1	NULL
,	NULL
FAK	NULL
,	NULL
Syk	NULL
,	NULL
or	NULL
paxillin	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
precipitated	NULL
immunocomplexes	NULL
were	NULL
analyzed	NULL
for	NULL
phosphotyrosyl-containing	NULL
proteins	NULL
by	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
the	NULL
respective	NULL
antibody	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

NAD	NULL
,	NULL
nonadherent	NULL
;	NULL
Fx	NULL
,	NULL
adherent	NULL
to	NULL
fibronectin	NULL
;	NULL
B1	NULL
,	NULL
ligated	NULL
with	NULL
TS2/16	NULL
;	NULL
Ig	NULL
,	NULL
ligated	NULL
with	NULL
intact	NULL
TS2/16	NULL
;	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
,	NULL
ligated	NULL
with	NULL
this	NULL
fragment	NULL
of	NULL
TS2/16	NULL
.	NULL

scription	NULL
of	NULL
certain	NULL
genes	NULL
.	NULL

Herbimycin	NULL
A	NULL
and	NULL
Genistein	NULL
Inhibit	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
IL-1B	NULL
Message	NULL
Expression	NULL
Induced	NULL
by	NULL
Cell	NULL
Adhesion	NULL
or	NULL
by	NULL
Ligation	NULL
of	NULL
B1	NULL
Integrins-To	NULL
evaluate	NULL
whether	NULL
tyrosine	NULL
phosphorylation	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
increased	NULL
message	NULL
levels	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
protein-tyrosine	NULL
kinase	NULL
inhibitors	NULL
and	NULL
examined	NULL
for	NULL
effects	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
IL-16	NULL
message	NULL
induction	NULL
.	NULL

Herbimycin	NULL
A	NULL
and	NULL
genistein	NULL
are	NULL
selective	NULL
inhibitors	NULL
of	NULL
tyrosine	NULL
kinases	NULL
with	NULL
distinct	NULL
mechanisms	NULL
of	NULL
action	NULL
;	NULL
herbimycin	NULL
A	NULL
blocks	NULL
tyrosine	NULL
kinases	NULL
by	NULL
attacking	NULL
critical	NULL
sulfhydryl	NULL
groups	NULL
(	NULL
36	NULL
)	NULL
,	NULL
while	NULL
genistein	NULL
inhibits	NULL
these	NULL
enzymes	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
ATP	NULL
binding	NULL
sites	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

44	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
demonstrates	NULL
that	NULL
treatment	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
herbimycin	NULL
A	NULL
resulted	NULL
in	NULL
an	NULL
inhibition	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
.	NULL

The	NULL
inhibition	NULL
was	NULL
dose	NULL
dependent	NULL
;	NULL
10	NULL
um	NULL
herbimycin	NULL
A	NULL
strongly	NULL
suppressed	NULL
the	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
while	NULL
2	NULL
um	NULL
was	NULL
less	NULL
effective	NULL
.	NULL

Expression	NULL
of	NULL
IL-16	NULL
mRNA	NULL
was	NULL
inhibited	NULL
by	NULL
herbimycin	NULL
A	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
the	NULL
effect	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

Another	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
,	NULL
genistein	NULL
,	NULL
also	NULL
exhibited	NULL
similar	NULL
inhibitory	NULL
effects	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
IL-16	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
;	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
genistein	NULL
were	NULL
noticeable	NULL
at	NULL
20	NULL
um	NULL
and	NULL
virtually	NULL
complete	NULL
at	NULL
100	NULL
un	NULL
.	NULL

As	NULL
in	NULL
the	NULL
case	NULL
of	NULL
adherence-induced	NULL
events	NULL
,	NULL
the	NULL
responses	NULL
induced	NULL
by	NULL
anti-B1	NULL
antibody	NULL
could	NULL
be	NULL
blocked	NULL
with	NULL
herbimycin	NULL
A	NULL
or	NULL
genistein	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
TS2/16-induced	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
IL-1B	NULL
expression	NULL
were	NULL
also	NULL
inhibited	NULL
by	NULL
herbimycin	NULL
A	NULL
or	NULL
genistein	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
responses	NULL
induced	NULL
by	NULL
integrin	NULL
ligation	NULL
or	NULL
by	NULL
adhesion	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
herbimycin	NULL
A	NULL
or	NULL
genistein	NULL
,	NULL
suggesting	NULL
that	NULL
integrin-mediated	NULL
increases	NULL
in	NULL
IL-1B	NULL
16194	NULL
TS2/16	NULL
NAD	NULL
Fn	NULL
1gG	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
We	NULL
wn	NULL
«	NULL
s	NULL
Syk	NULL
autophosphorylation	NULL
ears	NULL
.	NULL

.	NULL

amen	NULL
-	NULL
ene	NULL
Blot	NULL
:	NULL
anti-Syk	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
of	NULL
Syk	NULL
kinase	NULL
activity	NULL
by	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
or	NULL
by	NULL
Bl	NULL
integrin	NULL
ligation	NULL
.	NULL

Cell	NULL
lysates	NULL
obtained	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Syk	NULL
antibody	NULL
.	NULL

The	NULL
precipitated	NULL
Syk	NULL
kinase	NULL
was	NULL
analyzed	NULL
for	NULL
its	NULL
autophosphorylation	NULL
activity	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
with	NULL
the	NULL
kinase	NULL
assay	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
Syk	NULL
kinase	NULL
in	NULL
the	NULL
precipitated	NULL
immunocomplexes	NULL
was	NULL
examined	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

NAD	NULL
,	NULL
nonadherent	NULL
;	NULL
Fn	NULL
,	NULL
adherent	NULL
to	NULL
fibronectin	NULL
;	NULL
Ig	NULL
,	NULL
ligated	NULL
with	NULL
intact	NULL
TS2/16	NULL
;	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
;	NULL
,	NULL
ligated	NULL
with	NULL
this	NULL
fragment	NULL
of	NULL
TS2/16	NULL
.	NULL

Adhesion	NULL
to	NULL
Fn	NULL
__	NULL
B1	NULL
crosslinking	NULL
NAD	NULL
None	NULL
Her	NULL
.	NULL

Gen.	NULL
None	NULL
Her	NULL
.	NULL

Gen.	NULL
Syk	NULL
autophosphorylation	NULL
wt	NULL
wit	NULL
Cin	NULL
ww	NULL
tre	NULL
»	NULL
wit	NULL
wB	NULL
Blot	NULL
:	NULL
anti-Syk	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Inhibition	NULL
of	NULL
adhesion-	NULL
and	NULL
integrin	NULL
ligation-induced	NULL
Syk	NULL
kinase	NULL
activity	NULL
by	NULL
herbimycin	NULL
A	NULL
or	NULL
genistein	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
herbimycin	NULL
A	NULL
or	NULL
genistein	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Syk	NULL
kinase	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
and	NULL
analyzed	NULL
for	NULL
its	NULL
enzyme	NULL
activity	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
with	NULL
the	NULL
kinase	NULL
assay	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
Syk	NULL
kinase	NULL
in	NULL
the	NULL
precipitated	NULL
immunocomplexes	NULL
was	NULL
examined	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Her	NULL
.	NULL

,	NULL
10	NULL
um	NULL
herbimycin	NULL
A	NULL
;	NULL
Gen.	NULL
,	NULL
100	NULL
uM	NULL
genistein	NULL
.	NULL

message	NULL
levels	NULL
require	NULL
protein-tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

Identification	NULL
of	NULL
Proteins	NULL
Tyrosine	NULL
Phosphorylated	NULL
in	NULL
Response	NULL
to	NULL
Cell	NULL
Adhesion	NULL
to	NULL
a	NULL
Fibronectin	NULL
Substratum	NULL
or	NULL
to	NULL
Ligation	NULL
of	NULL
B1	NULL
Integrins	NULL
with	NULL
Antibodies-We	NULL
sought	NULL
to	NULL
identify	NULL
proteins	NULL
that	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
THP-1	NULL
cells	NULL
subsequent	NULL
to	NULL
engagement	NULL
of	NULL
integrins	NULL
,	NULL
which	NULL
might	NULL
be	NULL
important	NULL
in	NULL
integrin-mediated	NULL
message	NULL
induction	NULL
.	NULL

We	NULL
obtained	NULL
antibodies	NULL
to	NULL
several	NULL
proteins	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
cascades	NULL
or	NULL
in	NULL
cytoskeletal	NULL
organization	NULL
and	NULL
examined	NULL
their	NULL
tyrosine	NULL
phosphorylation	NULL
status	NULL
.	NULL

We	NULL
examined	NULL
FAK	NULL
(	NULL
125	NULL
kDa	NULL
)	NULL
as	NULL
a	NULL
possible	NULL
component	NULL
of	NULL
the	NULL
120-kDa	NULL
complex	NULL
and	NULL
Raf-1	NULL
(	NULL
74	NULL
kDa	NULL
)	NULL
,	NULL
PTP1D	NULL
(	NULL
72	NULL
kDa	NULL
)	NULL
,	NULL
paxillin	NULL
(	NULL
68	NULL
kDa	NULL
)	NULL
,	NULL
and	NULL
Syk	NULL
kinase	NULL
(	NULL
72	NULL
kDa	NULL
)	NULL
as	NULL
possible	NULL
components	NULL
of	NULL
the	NULL
65	NULL
kDa-75-kDa	NULL
complexes	NULL
.	NULL

Specific	NULL
antibodies	NULL
were	NULL
used	NULL
to	NULL
immunoprecipitate	NULL
these	NULL
potential	NULL
substrates	NULL
,	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
FAK	NULL
,	NULL
paxillin	NULL
,	NULL
and	NULL
Syk	NULL
kinase	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
upon	NULL
cell	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
;	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PTP1D	NULL
or	NULL
Raf	NULL
.	NULL

Only	NULL
Syk	NULL
kinase	NULL
,	NULL
but	NULL
not	NULL
FAK	NULL
or	NULL
paxillin	NULL
,	NULL
was	NULL
found	NULL
to	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
treatment	NULL
with	NULL
anti-Bl	NULL
integrin	NULL
antibody	NULL
.	NULL

The	NULL
induction	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
«	NULL
nau	NULL
seas	NULL
:	NULL
Blot	NULL
:	NULL
anti-PY	NULL
Blot	NULL
:	NULL
anti-Syk	NULL
|P	NULL
:	NULL
anti-FAK	NULL
Blot	NULL
:	NULL
anti-PY	NULL
Blot	NULL
:	NULL
anti-FAK	NULL
+	NULL
cytochalasin	NULL
D	NULL
®	NULL
.	NULL

``	NULL
x	NULL
.	NULL
``	NULL

98	NULL
)	NULL
JP	NULL
:	NULL
anti-Paxillin	NULL
<	NULL
i	NULL
C	NULL
Blot	NULL
:	NULL
anti-PY	NULL
NAD	NULL
ADH	NULL
a	NULL
minta	NULL
a	NULL
a	NULL
&	NULL
a	NULL
we	NULL
WP	NULL
WP	NULL
-IL-13	NULL
Blot	NULL
:	NULL
anti-Paxillin	NULL
#	NULL
WB	NULL
WB	NULL
WB	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
cytochalasin	NULL
D	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
IL-1	NULL
induction	NULL
.	NULL

A	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
and	NULL
spread	NULL
on	NULL
fibronectin-coated	NULL
dishes	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
cytochalasin	NULL
D	NULL
(	NULL
0.5	NULL
uM	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
before	NULL
being	NULL
photographed	NULL
at	NULL
300	NULL
%	NULL
magnification	NULL
.	NULL

B	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
nonadherently	NULL
or	NULL
plated	NULL
on	NULL
to	NULL
fibronectin-coated	NULL
dishes	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
0.5	NULL
M	NULL
cytochalasin	NULL
D	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Following	NULL
the	NULL
incubations	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
antibodies	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
precipitated	NULL
immunocomplexes	NULL
were	NULL
analyzed	NULL
for	NULL
phos-photyrosyl-containing	NULL
proteins	NULL
by	NULL
anti-phosphotyrosine	NULL
(	NULL
anti-PY¥	NULL
)	NULL
immunoblotting	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
the	NULL
respective	NULL
antibody	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

C	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
panel	NULL
B	NULL
for	NULL
1	NULL
h.	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
probed	NULL
with	NULL
IL-1	NULL
or	NULL
B-actin	NULL
probes	NULL
(	NULL
6	NULL
ug	NULL
total	NULL
RNA/lane	NULL
)	NULL
.	NULL

NAD	NULL
,	NULL
nonadherent	NULL
;	NULL
ADH	NULL
,	NULL
adherent	NULL
to	NULL
fibronectin	NULL
.	NULL

Syk	NULL
kinase	NULL
was	NULL
not	NULL
due	NULL
to	NULL
engagement	NULL
of	NULL
Fc	NULL
receptors	NULL
,	NULL
since	NULL
the	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragment	NULL
of	NULL
TS2/16	NULL
was	NULL
also	NULL
effective	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Syk	NULL
occurs	NULL
during	NULL
integrin-mediated	NULL
cell	NULL
adhesion	NULL
or	NULL
subsequent	NULL
to	NULL
integrin	NULL
ligation	NULL
by	NULL
antibodies	NULL
.	NULL

Immunodepletion	NULL
experiments	NULL
revealed	NULL
that	NULL
Syk	NULL
,	NULL
paxillin	NULL
,	NULL
and	NULL
FAK	NULL
contribute	NULL
to	NULL
the	NULL
overall	NULL
patterns	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
adhesion	NULL
or	NULL
integrin	NULL
ligation	NULL
with	NULL
antibody	NULL
,	NULL
but	NULL
they	NULL
do	NULL
not	NULL
fully	NULL
account	NULL
for	NULL
the	NULL
patterns	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
additional	NULL
unidentified	NULL
proteins	NULL
are	NULL
also	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
integrin	NULL
ligation	NULL
.	NULL

Activation	NULL
of	NULL
Syk	NULL
Kinase	NULL
by	NULL
Engagement	NULL
of	NULL
Integrins-Fol-lowing	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
through	NULL
integrins	NULL
,	NULL
there	NULL
were	NULL
significant	NULL
increases	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Syk	NULL
kinase	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
immunocomplex	NULL
kinase	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
nonadherent	NULL
THP-1	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
detectable	NULL
kinase	NULL
activity	NULL
,	NULL
but	NULL
the	NULL
activity	NULL
increased	NULL
4-	NULL
,	NULL
3.5-	NULL
,	NULL
and	NULL
3-fold	NULL
,	NULL
respectively	NULL
,	NULL
upon	NULL
cell	NULL
adhesion	NULL
to	NULL
a	NULL
fibronectin	NULL
substratum	NULL
,	NULL
ligation	NULL
of	NULL
B1	NULL
integrins	NULL
with	NULL
TS2/16	NULL
,	NULL
or	NULL
with	NULL
TS2/16	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
;	NULL
;	NULL
the	NULL
radioactivity	NULL
in	NULL
each	NULL
band	NULL
was	NULL
quantitated	NULL
using	NULL
a	NULL
PhosphorImager	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
herbimycin	NULL
A	NULL
and	NULL
genistein	NULL
suppressed	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
Syk	NULL
.	NULL

The	NULL
concentrations	NULL
of	NULL
inhibitors	NULL
required	NULL
to	NULL
block	NULL
Syk	NULL
activation	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
required	NULL
to	NULL
inhibit	NULL
the	NULL
overall	NULL
pattern	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
IL-18	NULL
message	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
Syk	NULL
is	NULL
an	NULL
integrin-responsive	NULL
tyrosine	NULL
kinase	NULL
whose	NULL
activation	NULL
parallels	NULL
,	NULL
and	NULL
may	NULL
impinge	NULL
on	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
cytokine	NULL
messages	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
Cytoskeleton-We	NULL
have	NULL
explored	NULL
the	NULL
role	NULL
of	NULL
the	NULL
cytoskeleton	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
IL-1	NULL
message	NULL
expression	NULL
by	NULL
use	NULL
of	NULL
the	NULL
drug	NULL
cytochalasin	NULL
D	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
actin	NULL
filament	NULL
assembly	NULL
(	NULL
38	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

84	NULL
,	NULL
treatment	NULL
with	NULL
cytochalasin	NULL
D	NULL
inhibits	NULL
spreading	NULL
of	NULL
THP-1	NULL
cells	NULL
on	NULL
fibronectin	NULL
but	NULL
does	NULL
not	NULL
affect	NULL
adhesion	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
FAK	NULL
,	NULL
and	NULL
particularly	NULL
of	NULL
paxillin	NULL
,	NULL
that	NULL
is	NULL
induced	NULL
in	NULL
THP-1	NULL
cells	NULL
by	NULL
interaction	NULL
with	NULL
a	NULL
fibronectin	NULL
substratum	NULL
is	NULL
strongly	NULL
inhibited	NULL
by	NULL
cytochalasin	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
some	NULL
degree	NULL
of	NULL
microfilament	NULL
assembly	NULL
is	NULL
required	NULL
for	NULL
these	NULL
phosphorylation	NULL
events	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
adhesion-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Syk	NULL
is	NULL
not	NULL
blocked	NULL
by	NULL
cytochalasin	NULL
D	NULL
treatment	NULL
;	NULL
likewise	NULL
,	NULL
IL-18	NULL
message	NULL
induction	NULL
is	NULL
not	NULL
affected	NULL
.	NULL

These	NULL
observations	NULL
clearly	NULL
distinguish	NULL
between	NULL
presumptive	NULL
integrin	NULL
signaling	NULL
events	NULL
that	NULL
require	NULL
actin	NULL
filament	NULL
assembly	NULL
and	NULL
events	NULL
such	NULL
as	NULL
Syk	NULL
activation	NULL
that	NULL
do	NULL
not	NULL
have	NULL
this	NULL
requirement	NULL
.	NULL

They	NULL
also	NULL
indicate	NULL
that	NULL
extensive	NULL
cytoskeletal	NULL
reorganization	NULL
is	NULL
not	NULL
required	NULL
for	NULL
integrin-mediated	NULL
increases	NULL
in	NULL
IL-1B	NULL
message	NULL
levels	NULL
.	NULL

DISCUSSION	NULL
Ligation	NULL
of	NULL
B1	NULL
integrins	NULL
in	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
results	NULL
in	NULL
a	NULL
prompt	NULL
and	NULL
robust	NULL
induction	NULL
of	NULL
a	NULL
number	NULL
of	NULL
inflammatory	NULL
mediator	NULL
genes	NULL
including	NULL
IL-1	NULL
,	NULL
IL-8	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
as	NULL
well	NULL
as	NULL
genes	NULL
for	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
B1	NULL
integrin	NULL
ligation	NULL
in	NULL
monocytes	NULL
also	NULL
results	NULL
in	NULL
a	NULL
burst	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
that	NULL
this	NULL
is	NULL
necessary	NULL
for	NULL
subsequent	NULL
integrin-mediated	NULL
gene	NULL
induction	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
similar	NULL
events	NULL
,	NULL
including	NULL
integrin-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
increases	NULL
in	NULL
inflammatory	NULL
gene	NULL
message	NULL
levels	NULL
,	NULL
also	NULL
occur	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
that	NULL
is	NULL
more	NULL
amenable	NULL
to	NULL
study	NULL
of	NULL
biochemical	NULL
and	NULL
molecular	NULL
events	NULL
than	NULL
are	NULL
primary	NULL
monocytes	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
integrin	NULL
ligation	NULL
.	NULL

Fur-ther	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
some	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
THP-1	NULL
cells	NULL
subsequent	NULL
to	NULL
integrin	NULL
ligation	NULL
;	NULL
these	NULL
include	NULL
the	NULL
focal	NULL
contact	NULL
protein	NULL
paxillin	NULL
and	NULL
the	NULL
FAK	NULL
and	NULL
Syk	NULL
non-receptor	NULL
tyrosine	NULL
kinases	NULL
.	NULL

The	NULL
patterns	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
in	NULL
THP-1	NULL
cells	NULL
by	NULL
integrin-mediated	NULL
cell	NULL
adhesion	NULL
or	NULL
by	NULL
antibody	NULL
ligation	NULL
of	NULL
B1	NULL
integrins	NULL
are	NULL
similar	NULL
but	NULL
distinct	NULL
.	NULL

Both	NULL
types	NULL
of	NULL
stimuli	NULL
result	NULL
in	NULL
prominent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
components	NULL
in	NULL
the	NULL
65-75-	NULL
and	NULL
the	NULL
115-125-kDa	NULL
ranges	NULL
.	NULL

However	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
whole	NULL
cell	NULL
lysates	NULL
,	NULL
integrin-mediated	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
produces	NULL
a	NULL
strong	NULL
doublet	NULL
at	NULL
65-75	NULL
kDa	NULL
,	NULL
while	NULL
antibody	NULL
ligation	NULL
results	NULL
primarily	NULL
in	NULL
phosphorylation	NULL
of	NULL
the	NULL
lower	NULL
molecular	NULL
mass	NULL
component	NULL
of	NULL
the	NULL
doublet	NULL
;	NULL
likewise	NULL
,	NULL
among	NULL
the	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
at	NULL
115-125	NULL
kDa	NULL
,	NULL
adhesion	NULL
results	NULL
in	NULL
strong	NULL
phosphorylation	NULL
of	NULL
a	NULL
slowly	NULL
migrating	NULL
component	NULL
(	NULL
120	NULL
kDa	NULL
)	NULL
,	NULL
while	NULL
antibody	NULL
ligation	NULL
primarily	NULL
affects	NULL
a	NULL
more	NULL
rapidly	NULL
migrating	NULL
component	NULL
(	NULL
115	NULL
kDa	NULL
)	NULL
.	NULL

The	NULL
basis	NULL
for	NULL
the	NULL
differences	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
patterns	NULL
in	NULL
THP-1	NULL
cells	NULL
stimulated	NULL
by	NULL
anti-integrin	NULL
antibodies	NULL
and	NULL
those	NULL
stimulated	NULL
by	NULL
integrin-mediated	NULL
cell	NULL
adhesion	NULL
is	NULL
unclear	NULL
at	NULL
this	NULL
time	NULL
.	NULL

One	NULL
reasonable	NULL
possibility	NULL
is	NULL
that	NULL
cell	NULL
adhesion	NULL
results	NULL
in	NULL
a	NULL
more	NULL
complete	NULL
engagement	NULL
of	NULL
the	NULL
cytoskeleton	NULL
than	NULL
does	NULL
the	NULL
formation	NULL
of	NULL
integrin	NULL
dimers	NULL
or	NULL
multimers	NULL
triggered	NULL
by	NULL
antibodies	NULL
and	NULL
the	NULL
degree	NULL
of	NULL
cytoskeletal	NULL
organization	NULL
can	NULL
affect	NULL
the	NULL
recruitment	NULL
of	NULL
proteins	NULL
subject	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Despite	NULL
differences	NULL
in	NULL
the	NULL
overall	NULL
patterns	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
cell	NULL
adhesion	NULL
or	NULL
by	NULL
antibody	NULL
ligation	NULL
of	NULL
integrins	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
both	NULL
of	NULL
these	NULL
stimuli	NULL
can	NULL
activate	NULL
NF-kB	NULL
and	NULL
can	NULL
give	NULL
rise	NULL
to	NULL
increased	NULL
levels	NULL
of	NULL
cytokine	NULL
mes	NULL
16195	NULL
sages	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
we	NULL
have	NULL
demonstrated	NULL
here	NULL
for	NULL
THP-1	NULL
cells	NULL
and	NULL
previously	NULL
for	NULL
monocytes	NULL
(	NULL
21	NULL
)	NULL
,	NULL
inhibitors	NULL
of	NULL
tyrosine	NULL
kinases	NULL
can	NULL
block	NULL
message	NULL
induction	NULL
mediated	NULL
by	NULL
cell	NULL
adhesion	NULL
or	NULL
by	NULL
ligation	NULL
of	NULL
B1	NULL
integrins	NULL
.	NULL

These	NULL
inhibitors	NULL
also	NULL
blocked	NULL
activation	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
driven	NULL
promoter-reporter	NULL
construct	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
highly	NULL
probable	NULL
that	NULL
integrin	NULL
engagement	NULL
can	NULL
trigger	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
the	NULL
control	NULL
of	NULL
inflammatory	NULL
mediator	NULL
genes	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
carefully	NULL
analyze	NULL
integrin-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
to	NULL
try	NULL
to	NULL
define	NULL
those	NULL
events	NULL
most	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
message	NULL
induction	NULL
process	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
THP-1	NULL
lysates	NULL
for	NULL
evidence	NULL
of	NULL
integrin-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
proteins	NULL
previously	NULL
identified	NULL
as	NULL
being	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
cascades	NULL
or	NULL
linked	NULL
to	NULL
integrin-dependent	NULL
cytoskeletal	NULL
reorgani-zation	NULL
.	NULL

In	NULL
THP-1	NULL
cells	NULL
,	NULL
the	NULL
focal	NULL
contact	NULL
protein	NULL
paxillin	NULL
and	NULL
the	NULL
cytoplasmic	NULL
tyrosine	NULL
kinases	NULL
FAK	NULL
and	NULL
Syk	NULL
became	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
integrin-mediated	NULL
cell	NULL
adhesion	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
FAK	NULL
by	NULL
integrin	NULL
ligation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
other	NULL
stimuli	NULL
,	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
35	NULL
,	NULL
39	NULL
)	NULL
;	NULL
paxillin	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
FAK	NULL
,	NULL
and	NULL
its	NULL
tyrosine	NULL
phosphorylation	NULL
seems	NULL
to	NULL
parallel	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
FAK	NULL
kinase	NULL
(	NULL
23	NULL
,	NULL
41	NULL
)	NULL
.	NULL

That	NULL
FAK	NULL
and	NULL
paxillin	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
during	NULL
THP-1	NULL
cell	NULL
adhesion	NULL
suggests	NULL
that	NULL
these	NULL
molecules	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
cytoskeletal	NULL
reorganization	NULL
and	NULL
formation	NULL
of	NULL
focal	NULL
adhesive	NULL
sites	NULL
in	NULL
these	NULL
cells	NULL
;	NULL
a	NULL
similar	NULL
role	NULL
for	NULL
these	NULL
proteins	NULL
has	NULL
been	NULL
postulated	NULL
in	NULL
fibroblasts	NULL
(	NULL
23	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Since	NULL
cytochalasin	NULL
D	NULL
effectively	NULL
blocks	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
FAK	NULL
and	NULL
paxillin	NULL
,	NULL
some	NULL
degree	NULL
of	NULL
cytoskeletal	NULL
organization	NULL
and	NULL
cell	NULL
spreading	NULL
seem	NULL
to	NULL
be	NULL
required	NULL
for	NULL
these	NULL
events	NULL
.	NULL

Ligation	NULL
of	NULL
B1	NULL
integrins	NULL
with	NULL
antibodies	NULL
did	NULL
not	NULL
result	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
FAK	NULL
or	NULL
paxillin	NULL
but	NULL
did	NULL
cause	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Syk	NULL
,	NULL
a	NULL
cytoplasmic	NULL
tyrosine	NULL
kinase	NULL
that	NULL
contains	NULL
SH2	NULL
domains	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
Syk	NULL
kinase	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
associate	NULL
with	NULL
several	NULL
receptors	NULL
,	NULL
including	NULL
the	NULL
antigen	NULL
receptors	NULL
on	NULL
B-cells	NULL
(	NULL
43	NULL
)	NULL
,	NULL
the	NULL
Fc	NULL
receptors	NULL
for	NULL
IgE	NULL
(	NULL
FeeRI	NULL
)	NULL
(	NULL
44	NULL
)	NULL
and	NULL
IgG	NULL
(	NULL
FoeyRI	NULL
,	NULL
FeyRIII	NULL
)	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
,	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Syk	NULL
kinase	NULL
becomes	NULL
activated	NULL
and	NULL
tyrosine	NULL
phosphorylated	NULL
when	NULL
those	NULL
receptors	NULL
bind	NULL
their	NULL
respective	NULL
ligands	NULL
.	NULL

A	NULL
consensus	NULL
motif	NULL
has	NULL
been	NULL
defined	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
receptors	NULL
that	NULL
bind	NULL
Syk	NULL
or	NULL
the	NULL
related	NULL
kinase	NULL
ZAPT7O0	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Impaired	NULL
signal	NULL
transduction	NULL
processes	NULL
have	NULL
been	NULL
found	NULL
in	NULL
Syk	NULL
kinase	NULL
negative	NULL
cells	NULL
or	NULL
in	NULL
cells	NULL
that	NULL
express	NULL
a	NULL
Syk	NULL
mutant	NULL
lacking	NULL
kinase	NULL
activity	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Since	NULL
Syk	NULL
can	NULL
be	NULL
activated	NULL
via	NULL
Fc	NULL
receptors	NULL
,	NULL
we	NULL
used	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
of	NULL
anti-integrin	NULL
antibodies	NULL
to	NULL
demonstrate	NULL
that	NULL
integrin	NULL
ligation	NULL
,	NULL
rather	NULL
than	NULL
Fc	NULL
receptor	NULL
engagement	NULL
,	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
Syk	NULL
enzymatic	NULL
activity	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
that	NULL
we	NULL
observed	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
Syk	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
integrin-mediated	NULL
adhesion	NULL
to	NULL
fibronectin	NULL
substrata	NULL
also	NULL
indicates	NULL
that	NULL
integrins	NULL
rather	NULL
than	NULL
Fc	NULL
receptors	NULL
are	NULL
involved	NULL
.	NULL

Since	NULL
integrin	NULL
cytoplasmic	NULL
domains	NULL
do	NULL
not	NULL
contain	NULL
any	NULL
obvious	NULL
homologies	NULL
to	NULL
the	NULL
Syk	NULL
binding	NULL
motif	NULL
found	NULL
in	NULL
other	NULL
cognate	NULL
receptors	NULL
(	NULL
26	NULL
)	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
integrins	NULL
and	NULL
Syk	NULL
is	NULL
indirect	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
co-immunoprecipitate	NULL
Syk	NULL
and	NULL
integrins	NULL
from	NULL
cell	NULL
lysates	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
in	NULL
platelets	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
Syk	NULL
kinase	NULL
can	NULL
be	NULL
activated	NULL
via	NULL
engagement	NULL
of	NULL
the	NULL
allb/fB3	NULL
integrin	NULL
by	NULL
fibrinogen	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
both	NULL
monocytic	NULL
cells	NULL
and	NULL
platelets	NULL
,	NULL
Syk	NULL
is	NULL
an	NULL
integrin-responsive	NULL
tyrosine	NULL
kinase	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
Syk	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
FAK	NULL
,	NULL
is	NULL
not	NULL
completely	NULL
dependent	NULL
on	NULL
cytoskeletal	NULL
assembly	NULL
as	NULL
observed	NULL
here	NULL
as	NULL
well	NULL
as	NULL
in	NULL
previous	NULL
studies	NULL
on	NULL
platelets	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
recent	NULL
investigations	NULL
in	NULL
rat	NULL
baso-	NULL
16196	NULL
philic	NULL
leukemia	NULL
cells	NULL
have	NULL
shown	NULL
that	NULL
cross-linking	NULL
of	NULL
the	NULL
FeeRI	NULL
receptor	NULL
can	NULL
trigger	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
paxillin	NULL
,	NULL
while	NULL
receptor	NULL
cross-linking	NULL
in	NULL
adherent	NULL
cells	NULL
can	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
FAK	NULL
and	NULL
a	NULL
stronger	NULL
phosphorylation	NULL
of	NULL
paxillin	NULL
(	NULL
47	NULL
,	NULL
49	NULL
)	NULL
.	NULL

These	NULL
results	NULL
may	NULL
have	NULL
similar	NULL
underlying	NULL
mechanisms	NULL
to	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
,	NULL
since	NULL
multi-valent	NULL
cross-linking	NULL
of	NULL
FceeRI	NULL
receptors	NULL
may	NULL
cause	NULL
engagement	NULL
of	NULL
the	NULL
cytoskeleton	NULL
,	NULL
setting	NULL
the	NULL
stage	NULL
for	NULL
FAK	NULL
and	NULL
paxillin	NULL
phosphorylation	NULL
.	NULL

Either	NULL
integrin-mediated	NULL
cell	NULL
adhesion	NULL
or	NULL
antibody	NULL
ligation	NULL
of	NULL
integrins	NULL
can	NULL
effectively	NULL
increase	NULL
IL-1B	NULL
message	NULL
levels	NULL
,	NULL
as	NULL
well	NULL
as	NULL
causing	NULL
changes	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

However	NULL
,	NULL
antibody	NULL
ligation	NULL
affected	NULL
the	NULL
Syk	NULL
tyrosine	NULL
kinase	NULL
but	NULL
not	NULL
FAK	NULL
or	NULL
its	NULL
substrate	NULL
paxillin	NULL
.	NULL

Furthermore	NULL
,	NULL
treatment	NULL
with	NULL
cytochalasin	NULL
D	NULL
,	NULL
which	NULL
effectively	NULL
blocked	NULL
cell	NULL
spreading	NULL
and	NULL
FAK	NULL
and	NULL
paxillin	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
failed	NULL
to	NULL
block	NULL
Syk	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
increases	NULL
in	NULL
IL-1B	NULL
message	NULL
levels	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
that	NULL
FAK	NULL
is	NULL
not	NULL
required	NULL
for	NULL
integrin-mediated	NULL
IL-18	NULL
message	NULL
induction	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
observations	NULL
on	NULL
primary	NULL
monocytes	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
Syk	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
process	NULL
leading	NULL
from	NULL
integrin	NULL
engagement	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
inflammatory	NULL
mediator	NULL
genes	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
Syk	NULL
uniformly	NULL
precedes	NULL
and	NULL
accompanies	NULL
integrin-mediated	NULL
gene	NULL
induction	NULL
,	NULL
while	NULL
similar	NULL
concentrations	NULL
of	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
block	NULL
both	NULL
Syk	NULL
autophosphorylation	NULL
and	NULL
IL-1B	NULL
message	NULL
induction	NULL
.	NULL

The	NULL
integrin-mediated	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
Syk	NULL
activation	NULL
are	NULL
transient	NULL
even	NULL
during	NULL
continued	NULL
cell	NULL
adhesion	NULL
or	NULL
antibody	NULL
ligation	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
these	NULL
processes	NULL
are	NULL
regulated	NULL
,	NULL
perhaps	NULL
through	NULL
the	NULL
agency	NULL
of	NULL
protein	NULL
phosphatases	NULL
that	NULL
are	NULL
induced	NULL
or	NULL
activated	NULL
subsequent	NULL
to	NULL
integrin	NULL
stimulation	NULL
.	NULL

Similar	NULL
events	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
the	NULL
regulation	NULL
of	NULL
kinase	NULL
activities	NULL
stimulated	NULL
by	NULL
mitogens	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Current	NULL
evidence	NULL
indicates	NULL
that	NULL
Syk	NULL
is	NULL
an	NULL
integrin-responsive	NULL
tyrosine	NULL
kinase	NULL
.	NULL

It	NULL
also	NULL
suggests	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
monocytic	NULL
cells	NULL
that	NULL
involves	NULL
the	NULL
ligation	NULL
of	NULL
integrins	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
Syk	NULL
tyrosine	NULL
kinase	NULL
,	NULL
the	NULL
triggering	NULL
of	NULL
downstream	NULL
events	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
eventual	NULL
induction	NULL
of	NULL
messages	NULL
for	NULL
inflammatory	NULL
mediator	NULL
genes	NULL
.	NULL

Extensive	NULL
cytoskeletal	NULL
reorganization	NULL
does	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
required	NULL
in	NULL
this	NULL
pathway	NULL
,	NULL
since	NULL
cytochalasin	NULL
D	NULL
treatment	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
IL-1B	NULL
message	NULL
levels	NULL
.	NULL

In	NULL
those	NULL
types	NULL
of	NULL
monocytic	NULL
cells	NULL
that	NULL
do	NULL
express	NULL
FAK	NULL
,	NULL
such	NULL
as	NULL
THP-1	NULL
,	NULL
there	NULL
is	NULL
a	NULL
second	NULL
integrin-mediated	NULL
signaling	NULL
pathway	NULL
that	NULL
involves	NULL
FAK	NULL
activation	NULL
,	NULL
and	NULL
that	NULL
seems	NULL
to	NULL
impact	NULL
primarily	NULL
on	NULL
cytoskeletal	NULL
organization	NULL
rather	NULL
than	NULL
gene	NULL
induction	NULL
.	NULL

At	NULL
this	NULL
point	NULL
,	NULL
a	NULL
number	NULL
of	NULL
issues	NULL
require	NULL
further	NULL
study	NULL
.	NULL

It	NULL
is	NULL
not	NULL
certain	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
Syk	NULL
tyrosine	NULL
kinase	NULL
is	NULL
essential	NULL
for	NULL
integrin-mediated	NULL
gene	NULL
induction	NULL
,	NULL
as	NULL
opposed	NULL
to	NULL
simply	NULL
accompanying	NULL
the	NULL
induction	NULL
process	NULL
,	NULL
nor	NULL
can	NULL
the	NULL
participation	NULL
of	NULL
additional	NULL
tyrosine	NULL
kinases	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

Further	NULL
experiments	NULL
will	NULL
be	NULL
required	NULL
to	NULL
establish	NULL
a	NULL
causal	NULL
role	NULL
for	NULL
Syk	NULL
in	NULL
integrin	NULL
signaling	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
downstream	NULL
events	NULL
linking	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
to	NULL
alterations	NULL
of	NULL
inflammatory	NULL
gene	NULL
message	NULL
levels	NULL
remain	NULL
to	NULL
be	NULL
defined	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
integrin	NULL
ligation	NULL
induces	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-1	NULL
gene	NULL
but	NULL
does	NULL
not	NULL
affect	NULL
message	NULL
stabil-ity	NULL
.	NULL

?	NULL

In	NULL
the	NULL
THP-1	NULL
cell	NULL
system	NULL
,	NULL
integrin	NULL
ligation	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
NF-KB	NULL
,	NULL
increased	NULL
transcription	NULL
from	NULL
NF-	NULL
«	NULL
B-driven	NULL
reporter	NULL
constructs	NULL
,	NULL
and	NULL
increases	NULL
in	NULL
IL-1B	NULL
message	NULL
levels	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
present	NULL
if	NULL
integrin-mediated	NULL
changes	NULL
°	NULL
Lofquist	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Haskill	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1737-1746	NULL
.	NULL

Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
in	NULL
IL-1B	NULL
message	NULL
levels	NULL
in	NULL
THP-1	NULL
cells	NULL
are	NULL
primarily	NULL
controlled	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
or	NULL
by	NULL
other	NULL
means	NULL
,	NULL
such	NULL
as	NULL
changes	NULL
in	NULL
message	NULL
stability	NULL
or	NULL
RNA	NULL
splicing	NULL
.	NULL

If	NULL
transcriptional	NULL
activation	NULL
does	NULL
occur	NULL
,	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
remains	NULL
to	NULL
be	NULL
defined	NULL
.	NULL

Despite	NULL
these	NULL
ques-tions	NULL
,	NULL
current	NULL
observations	NULL
provide	NULL
important	NULL
initial	NULL
insights	NULL
into	NULL
integrin	NULL
signal	NULL
transduction	NULL
processes	NULL
in	NULL
monocytic	NULL
cells	NULL
and	NULL
emphasize	NULL
a	NULL
key	NULL
role	NULL
for	NULL
specific	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Drs	NULL
.	NULL

A.	NULL
Baldwin	NULL
and	NULL
D.	NULL
Brenner	NULL
of	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
for	NULL
providing	NULL
reporter	NULL
gene	NULL
constructs	NULL
and	NULL
advice	NULL
and	NULL
Dr.	NULL
M.	NULL
Hemler	NULL
of	NULL
Harvard	NULL
for	NULL
providing	NULL
the	NULL
TS2/16	NULL
hybridoma	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
J	NULL
.	NULL

A.	NULL
Hughes	NULL
for	NULL
help	NULL
with	NULL
flow	NULL
cytometry	NULL
analysis	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bevilacqua	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11	NULL
,	NULL
767-804	NULL
2	NULL
.	NULL

Hemler	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Ann	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
365-400	NULL
3	NULL
.	NULL

Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Xiaoping	NULL
,	NULL
D.	NULL
,	NULL
O'Toole	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Loftus	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Plow	NULL
,	NULL
E.	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Thromb	NULL
.	NULL

Haemostasis	NULL
70	NULL
,	NULL
87-93	NULL
4	NULL
.	NULL

Ruoslahti	NULL
,	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87	NULL
,	NULL
1-5	NULL
5	NULL
.	NULL

Juliano	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Haskill	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

120	NULL
,	NULL
577-585	NULL
6	NULL
.	NULL

Hanks	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Calalb	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Harper	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Patel	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
8487-8491	NULL
7	NULL
.	NULL

Sinnett-Smith	NULL
,	NULL
J.	NULL
,	NULL
Zachary	NULL
,	NULL
L.	NULL
,	NULL
Valverde	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
Rozengurt	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
14261-14268	NULL
8	NULL
.	NULL

Schaller	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Borgman	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Cobb	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Vines	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Reynolds	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Parsons	NULL
,	NULL
J.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
5192-5196	NULL
9	NULL
.	NULL

Schwartz	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

120	NULL
,	NULL
1003-1010	NULL
10	NULL
.	NULL

Schwartz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Lechene	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Ingber	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7849-7853	NULL
11	NULL
.	NULL

Arcangeli	NULL
,	NULL
A.	NULL
,	NULL
Becchetti	NULL
,	NULL
A.	NULL
,	NULL
Mannini	NULL
,	NULL
A.	NULL
,	NULL
Mugnai	NULL
,	NULL
G.	NULL
,	NULL
De	NULL
Filippi	NULL
,	NULL
P.	NULL
,	NULL
Tarone	NULL
,	NULL
G.	NULL
,	NULL
Del	NULL
Bene	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Barletta	NULL
,	NULL
E.	NULL
,	NULL
Wanke	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Olivotto	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

122	NULL
,	NULL
1131-1148	NULL
12	NULL
.	NULL

Vuori	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ruoslahti	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21459-21462	NULL
13	NULL
.	NULL

Rosales	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Juliano	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

57	NULL
,	NULL
189-198	NULL
14	NULL
.	NULL

Schmidhauser	NULL
,	NULL
C.	NULL
,	NULL
Bissell	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Myers	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Casperson	NULL
,	NULL
G.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9118-9122	NULL
15	NULL
.	NULL

Damsky	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Werb	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

4	NULL
,	NULL
772-781	NULL
16	NULL
.	NULL

Streuli	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Bissell	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

110	NULL
,	NULL
1405-1415	NULL
17	NULL
.	NULL

Werb	NULL
,	NULL
Z.	NULL
,	NULL
Tremble	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Behrendtsen	NULL
,	NULL
O.	NULL
,	NULL
Crowley	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Damsky	NULL
,	NULL
C.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

109	NULL
,	NULL
877-889	NULL
18	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Johnson	NULL
,	NULL
C.	NULL
,	NULL
Eierman	NULL
,	NULL
D.	NULL
,	NULL
Becker	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Warren	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
1690-1694	NULL
19	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1281-1289	NULL
20	NULL
.	NULL

Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Liu	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
Eierman	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Haskill	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
9034-9038	NULL
21	NULL
.	NULL

Lin	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
,	NULL
Kornberg	NULL
,	NULL
L.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
,	NULL
Walker	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Juliano	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

126	NULL
,	NULL
1585-1593	NULL
22	NULL
.	NULL

Schaller	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
Parsons	NULL
,	NULL
J.	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

8	NULL
,	NULL
258-262	NULL
23	NULL
.	NULL

Burridge	NULL
,	NULL
K.	NULL
,	NULL
Turner	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
and	NULL
Romer	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

119	NULL
,	NULL
893-903	NULL
24	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
Kobayashi	NULL
,	NULL
T.	NULL
,	NULL
Kondo	NULL
,	NULL
J.	NULL
,	NULL
Takahashi	NULL
,	NULL
K.	NULL
,	NULL
Nakamura	NULL
,	NULL
H.	NULL
,	NULL
Suzuki	NULL
,	NULL
J.	NULL
,	NULL
Nagai	NULL
,	NULL
K.	NULL
,	NULL
Yamada	NULL
,	NULL
T.	NULL
,	NULL
Nakamura	NULL
,	NULL
S.-L	NULL
,	NULL
and	NULL
Yamamura	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
15790-15796	NULL
25	NULL
.	NULL

Law	NULL
,	NULL
C.-L.	NULL
,	NULL
Sidorenko	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Chandran	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Draves	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Weiss	NULL
,	NULL
A.	NULL
,	NULL
Edelhoff	NULL
,	NULL
S.	NULL
,	NULL
Disteche	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
12310-12319	NULL
26	NULL
.	NULL

Corey	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Burkhardt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Geahlen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Tkatch	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
and	NULL
Tweardy	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
4683-4687	NULL
27	NULL
.	NULL

Shaw	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Messier	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Mercurio	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

110	NULL
,	NULL
2167-2174	NULL
28	NULL
.	NULL

Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6089-6101	NULL
29	NULL
.	NULL

Rippe	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Brenner	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Leffert	NULL
,	NULL
H.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
689-695	NULL
30	NULL
.	NULL

Westwick	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Cox	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Der	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Cobb	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Brenner	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
6030-6034	NULL
31	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Donald	NULL
,	NULL
R.	NULL
,	NULL
Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11803-11810	NULL
32	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
33	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
MacKichan	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Celf	NULL
71	NULL
,	NULL
243-253	NULL
34	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
35	NULL
.	NULL

Kornberg	NULL
,	NULL
L.	NULL
,	NULL
Earp	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Parsons	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Schaller	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Juliano	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
,	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
23439-23442	NULL
36	NULL
.	NULL

Uehara	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Fukazawa	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

201	NULL
,	NULL
370-379	NULL
37	NULL
.	NULL

Akiyama	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ogawara	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

201	NULL
,	NULL
362-370	NULL
38	NULL
.	NULL

Franki	NULL
,	NULL
N.	NULL
,	NULL
Ding	NULL
,	NULL
G.	NULL
,	NULL
Gao	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hays	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

263	NULL
,	NULL
995-1000	NULL
39	NULL
.	NULL

Lipfert	NULL
,	NULL
L.	NULL
,	NULL
Haimovich	NULL
,	NULL
B.	NULL
,	NULL
Schaller	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Cobb	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Parsons	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
Brugge	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

119	NULL
,	NULL
905-912	NULL
40	NULL
.	NULL

Sun	NULL
,	NULL
H.	NULL
,	NULL
Tonks	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
and	NULL
Bar-Sagi	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
285-288	NULL
41	NULL
.	NULL

Turner	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
BioEssays	NULL
16	NULL
,	NULL
47-52	NULL
42	NULL
.	NULL

Bockholt	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Burridge	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
14565-14567	NULL
43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Cytokine	NULL
Message	NULL
Induction	NULL
16197	NULL
Takata	NULL
,	NULL
M.	NULL
,	NULL
Sabe	NULL
,	NULL
H.	NULL
,	NULL
Hata	NULL
,	NULL
A.	NULL
,	NULL
Inazu	NULL
,	NULL
T.	NULL
,	NULL
Homma	NULL
,	NULL
Y.	NULL
,	NULL
Mukada	NULL
,	NULL
T.	NULL
,	NULL
Yamamura	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kurosaki	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1341-1349	NULL
Benhamou	NULL
,	NULL
M.	NULL
,	NULL
Ryba	NULL
,	NULL
N.	NULL
J.	NULL
P.	NULL
,	NULL
Kihara	NULL
,	NULL
H.	NULL
,	NULL
Nishikata	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Siraganian	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
23318-23324	NULL
Darby	NULL
,	NULL
C.	NULL
,	NULL
Geahlen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
5429-5437	NULL
Kiener	NULL
,	NULL
P.	NULL
,	NULL
Rankin	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Burkhardt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Gilliland	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Rowley	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
24442-24448	NULL
Hamawy	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Mergenhagen	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Siraganian	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
6851-6854	NULL
48	NULL
.	NULL

Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Shattil	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Bolen	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Brugge	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
28859-28864	NULL
49	NULL
.	NULL

Hamawy	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Oliver	NULL
,	NULL
C.	NULL
,	NULL
Mergenhagen	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Siraganian	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
615-621	NULL
50	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
(	NULL
Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Strubl	NULL
,	NULL
K.	NULL
,	NULL
eds	NULL
)	NULL
CD	NULL
Version	NULL
,	NULL
Chapter	NULL
9.1	NULL
,	NULL
J.	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
51	NULL
.	NULL

Titus	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Promega	NULL
Protocols	NULL
and	NULL
Applications	NULL
Guide	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
pp	NULL
.	NULL

285-296	NULL
,	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL

